shannon willhite finks - uthsc · shannon w. finks, pharm.d., fccp, bcps, bccp, ahscp-chc 1...

Shannon W. Finks, Pharm.D., FCCP, BCPS, BCCP, AHSCP-CHC

1

CURRICULUM VITAE

Shannon Willhite Finks

Last Updated 12.10.18

PERSONAL INFORMATION

Business address Home address

Professor of Clinical Pharmacy 2975 Tishomingo Lane University of Tennessee College of Pharmacy Memphis, TN 38111

881 Madison Avenue, Room 459 Memphis, TN 38163 Office : (901)448-3701 Fax: (901)448-1741 [email protected]

Birthday: January 6, 1974

Birthplace: Martin, Tennessee

EDUCATION AND TRAINING Undergraduate

Pre-Pharmacy curriculum August 1992 to May 1994 Harding University Searcy, Arkansas Graduate

Doctor of Pharmacy August 1994 to June 1998 With Honors The University of Tennessee

College of Pharmacy Memphis, Tennessee Postgraduate Training

ASHP Accredited Pharmacy Practice Residency June 1998 to June 1999 Methodist Healthcare—Memphis Hospitals

Memphis, Tennessee Director: Daniel M. Ashby, MS, FASHP HONORS AND AWARDS

Academic 1998 Graduating with honors, University of Tennessee College of Pharmacy

1998 The National Dean’s List 1998 Recipient of Virginia Eoff Scholarship


2

Education and Teaching

2018 SGAEC Excellence in Teaching Award, UTHSC College of Pharmacy 2017 Cardiology PRN Mentorship Award, American College of Clinical Pharmacy 2012 UT Alumni Association Outstanding Teacher Award 2010 Most Influential Professor Award, from the Class of 2012 2010 Invited Graduation Address Speaker, University of Tennessee College of Pharmacy 2009 Inducted, Rho Chi Pharmaceutical Honor Society Leadership and Service 2017 Cardiology PRN Mentorship Award, American College of Clinical Pharmacy 2016 Cardiology PRN Service Award, American College of Clinical Pharmacy 2015 Cardiology PRN Past Chair Award, Americna College of Clinical Pharmacy 2011 Fellow, American College of Clinical Pharmacy 2010 ACCP Volunteer Recognition 2010 Mid-South College of Clinical Pharmacy Past President Award 1998 ASP Outstanding Graduating Student Award

1997 Outstanding Young Women of America 1997 The University of Tennessee, Memphis IMHOTEP Leadership Society 1996 Phi Lamda Sigma Pharmacy Leadership Society 1996 Outstanding ASP Student of the Year

Miscellaneous 2016 Who’s Who in America 2007 Arkansas Traveler Award 2007 Local media representative for medical/pharmacy interviews, University of Tennessee

Memphis, (2007 to present) 2000 Local media representative for medical/pharmacy interviews, Baptist Memorial Hospital,

(2000 to 2005) 2000 Mid South College of Clinical Pharmacy BCPS Award Recipient 1999 Pharmacy Miracle Award, Methodist Healthcare 1998 Mylan Excellence in Pharmacy Award

1998 Who’s Who Among Students in American Universities and Colleges 1997 National Finalist, ASHP National Clinical Skills Competition 1997 First Place, University of Tennessee College of Pharmacy Clinical Skills Competition 1994 Individual Sportsmanship Award, Harding University

National 2012 Mentor to Jacob Marler, Pharm.D. candidate. Finalist, American College of Clinical

Pharmacy’s (ACCP) Best Resident and Student Poster competition. “Safety outcomes in high risk patients receiving triple therapy after percutaneous coronary intervention.” ACCP 2012 Virtual Poster Symposium, May 22-24, 2012.

2010 Mentor to Maria Pham, Pharm.D., PGY-1. Finalist, American college of Clinical

Pharmacy’s Best Resident and Student Poster competition.

2010 Mentor to Johanna Norman, Pharm.D. candidate, Recipient, American College of Clinical Pharmacy’s (ACCP) Best Resident and Student Poster competition.


3

2001 Second Place, The Clinical Pharmacist’s Role in Implementing Expanded Indications for Low Molecular Weight Heparin Bridging Program. National Hospital Pharmacy Quality Awards, for December 2nd, 2001

2001 Honorable Mention, The Clinical Pharmacist’s Role in Providing Safe Dofetilide Medication Use: Initiation of a Critical Pathway to Avoid Adverse Drug Events and Complications from Antiarrhythmic Therapy. National Hospital Pharmacy Quality Awards, December 2nd, 2001.

BOARD CERTIFICATION

Added Qualifications (AQ) Cardiology Granted by the Board of Pharmaceutical Specialties, 2006 Credentials renewed and granted 2013-2018 (replaced with BCCP)

Board Certified Pharmacotherapy Specialist #200270 Certified by the Board of Pharmaceutical Specialties in December 2000 Recertified in April 2007, 2014 Board Certified Cardiology Pharmacist Certified by the Board of Pharmaceutical Specialties in November 2018 OTHER CERTIFICATION

Advanced Cardiac Life Support Instructor

Certified by the American Heart Association. September 2001, 2003, 2005, 2007, 2009, 2011, 2013, 2015,2017

Advanced Cardiac Life Support Provider Certified by the American Heart Association. April 1999, 2001, 2003, 2005, 2007, 2009, 2011, 2013, 2015, 2017

American Heart Association Healthcare Instructor Certified by the American Heart Association. July 2007, 2009, 2011, 2013, 2015, 2017 American Heart Association Healthcare Provider

Certified by the American Heart Association. March 1997, 1999, 2002,2004, 2007, 2009, 2011, 2013, 2015, 2017

American Society of Hypertension- Certified Hypertension Specialist (ASH-CHC) Certified by the American Society of Hypertension. August 2016. Pharmacy- Based Immunization Delivery Certification Certified by The University of Tennessee College of Pharmacy. January 9, 2008 Pharmaceutical Care for Patients with Diabetes. A Certificate Program For Pharmacists

Certified by American Pharmaceutical Association/ AADE. Memphis, TN. October 14-15, 2000

Diabetes Patient Care Certificate Program for Pharmacists Certified by the University of Tennessee College of Pharmacy, Memphis, TN. December 2-4, 1998


4

Asthma/Rhinitis Patient Care Certificate Program for Pharmacists

Certified by the University of Tennessee College of Pharmacy, Memphis, TN. November 30-December 1, 1998

LICENSURE Tennessee Board of Pharmacy #10549. Issued June 1998. Active status.

GRANTS

CourseDirector’s/Instructor’sInterpretationofItemAnalysisforIntegratedExaminationsandSubsequentImpactonStudentAcademicPerformance Submitted to UTCOP Scholarship of Teaching and Learning Seed Grant Program 2013. Accepted and fully funded for $1600, August 12, 2013.

PROFESSIONAL MEMBERSHIPS

American Association of Colleges of Pharmacy (AACP) American College of Cardiology (ACC), Associate Member American College of Chest Physicians, Allied Health Member (ACCP) American College of Clinical Pharmacy (ACCP) American Heart Association (AHA) American Pharmaceutical Association (APhA) American Society of Health-System Pharmacists (ASHP) Memphis Area Pharmacists Society (MAPS) Mid South College of Clinical Pharmacy (MSCCP) Phi Lambda Sigma Pharmacy Leadership Society, Theta Chapter Southern Medical Association (SMA) Kappa Psi Pharmaceutical Fraternity, Psi Chapter Tennessee Pharmacists Association (TPA)

UNIVERSITY APPOINTMENTS

Professor of Clinical Pharmacy and Translational Science 2016 to present University of Tennessee Health Science Center Memphis, Tennessee

Associate Professor of Clinical Pharmacy 2009 to 2016 University of Tennessee Health Science Center Memphis, Tennessee


5

Assistant Professor of Clinical Pharmacy 2000 to 2009 University of Tennessee Health Science Center

Memphis, Tennessee Clinical Assistant Professor of Pharmacy 2000 to 2005 University of Mississippi School of Pharmacy

Jackson, Mississippi Pharmacology Instructor Spring semester 1998 State Technical Institute Memphis, Tennessee

Pharmacology Instructor Fall semester 1998 University of Memphis Loewenberg School of Nursing Memphis, Tennessee

HOSPITAL/CLINICAL APPOINTMENTS

Clinical Pharmacy Specialist, Cardiology May 2006 to present VA Medical Center Memphis, Tennessee Supervisor: Kevin Freeman, Pharm.D.

Clinical Pharmacy Specialist, Cardiology August 1999 to July 2005 Baptist Memorial Hospital Memphis

Memphis, Tennessee Clinical Director: Bryan Love, PharmD, BCPS Pharmacy Director: Richard Nance, MS, BSPharm Patient Care Area Pharmacist June 1998 to June 1999 Methodist Healthcare—Central Hospital Memphis, Tennessee Supervisor: Lance Swearingen, MS Pharmacy Intern June 1994-March 1995

St. Jude Children’s Research Hospital Memphis, Tennessee Supervisor: William Kendall, RPh Pharmacy Intern November 1991-March 1992 Medical Center Pharmacy Martin, Tennessee Supervisor: Benny Dedmon, RPh


6

OTHER PROFESSIONAL APPOINTMENTS

PSAP-VII Editorial Board October 2009 to June 2012

American College of Clinical Pharmacy Chair: Michelle M. Richardson, Pharm.D., FCCP, BCPS

Clinical Director of Disease Management, Consultant September 2005 to 2006 Memphis Managed Care Corporation Mid South Health Solutions Vice President: Renee Trammell

TEACHING EXPERIENCE 2018-2019 The University of Tennessee College of Pharmacy

PHCY 1101, Fundamentals of Drug Action. Lecturer, 1 student contact hour, 202 students Lecture: Active Learning III: Therapeutic Drug Monitoring (1 hour)

PHCY 2100, Endocrinology Therapeutics. Lecturer, 2 student contact hours, 172 students Lecture: Obesity Therapeutics (2 hours) PHCY 1105_44588_201740, IPECS 1. Interprofessional session between UTCOP and College of Nursing. Lecturer, 2 content hours, 202 pharmacy students and 60 nursing students. Lecture topic: Hypertension interprofessional education (2 divided sessions, 2 hours each) November 30, 2018.

2017-2018 The University of Tennessee College of Pharmacy PHCY 211, Therapeutics I , Lecturer, 10 student contact hours, 181 students

Lecture topics: Primary Prevention of Heart Disease (2 hours), Hypertension (4 hours), Atherosclerosis and Dyslipidemia (4 hours)

PHCY 1105_44588_201740, IPECS 1. Lecturer, 2 content hours, 171 students Lecture topic: Cardiovascular Risk Assessment and Primary Prevention of Coronary Disease. August 28, 2017. PHCY 1105_44588_201740, IPECS 1. Interprofessional session between UTCOP and College of Nursing. Lecturer, 2 content hours, 171 pharmacy students and 60 nursing students. Lecture topic: Hypertension interprofessional education (2 divided sessions, 2 hours each) December 1, 2017.

CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 2 students Fall semester 2016 (Nadine Majaj, Sara Atyia)


7

PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 34 students. 30 contact hours. PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis. PHCY 260, Cardiopulmonary Resuscitation CPR Elective

Lecturer, 6 contact hours, 22 students (May 9, 2018)

Resident Teaching and Learning Certificate Program. Lecturer. 60 residents statewide. 2 lecture hours. August 2017. PHCY 1200_226662_201820, Cardiology I. Lecturer, 10 student contact hours, 171 students. Lecture topics: Primary Prevention of Heart Disease (2 hours), Atherosclerosis and Dyslipidemia (4 hours), Recitation hours (2). PHCY 1201_22663_201820, Cardiology II. Lecturer, 6 student contact hours, 171 students. Lecture topics: Hypertension (4 hours), Recitation hours (2)

2016-2017 The University of Tennessee College of Pharmacy

PHCY 211, Therapeutics I , Lecturer, 10 student contact hours, 195 students

Lecture topics: Primary Prevention of Heart Disease (2 hours), Hypertension (4 hours), Atherosclerosis and Dyslipidemia (4 hours)

PHCY 117, IPECS 1. Lecturer, 2 content hours, 176 students Lecture topic: Cardiovascular Risk Assessment and Primary Prevention of Coronary Disease. Sept 14,15, 2016. PHCY 117, IPECS 1. Interprofessional session between UTCOP and College of Nursing. Lecturer, 2 content hours, 176 pharmacy students and 60 nursing students. Lecture topic: Hypertension interprofessional education (3 divided sessions, 2 hours each) November 9-10, 2016.

CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 2 students Fall semester 2016 (Nadine Majaj, Sara Atyia) PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 34 students. 30 contact hours. PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis. PHCY 260, Cardiopulmonary Resuscitation CPR Elective


Resident Teaching and Learning Certificate Program. Lecturer. 60 residents statewide. 2 lecture hours. 1.10.17


8



Lecture topics: Primary Prevention of Heart Disease (2 hours), Hypertension (4 hours)

PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 18 students. 30 contact hours. PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis.

PHCY 117, IPECS 1. Lecturer, 2 content hours, 206 students Lecture topic: Cardiovascular Risk Assessment and Primary Prevention of Coronary Disease. PHCY 117, IPECS 1. Interprofessional session between UTCOP and College of Nursing. Lecturer, 2 content hours, 206 pharmacy students and 60 nursing students. Lecture topic: Hypertension interprofessional education (3 divided sessions, 2 hours each) CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 2 students Fall semester 2015 (Carmen Esch, Nadine Majaj) CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 2 students Spring semester 2015 (Megan Lowe, Nadine Majaj)

PHCY 260, Cardiopulmonary Resuscitation CPR Elective




PHCY 211, Therapeutics I , Lecturer, 7 student contact hours, 150 students Lecture topics: Primary Prevention of Heart Disease (2 hours)

Hypertension (4 hours)

PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 10 students. VA Medical Center, Memphis.

PHCY 117, IPECS 1. Lecturer, 2 content hours, 181 students Lecture topic: Cardiovascular Risk Assessment and Primary Prevention of Coronary Disease. PHCY 217, IPECS 3. Lecturer, 4 content hours, 160 students. Lecture topic: Atrial fibrillation.


9

CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 4 students Fall semester 2014 (Penny Cronk Bland, Jennee Nickleson, Melanie Shelton and Devlin Smith ) PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 18 students. 24 lecture hours.

PHCY 260, Cardiopulmonary Resuscitation CPR Elective Lecturer, 6 contact hours, 18 students (May 12, 2015)


St. George’s Medical School BIOE 501, Visiting Professorship, Contributing facilitator in the course “Bioethics and the Professional”. St. George’s University Medical School. St. Georges, Grenada (West Indies). January 11-24, 2015. 24 student contact hours; 64 students (8 groups of 8 students).



Hypertension (4 hours)


CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 2 students Fall semester 2013 (Penny Cronk Bland, Molly Kinsella) PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 18 students. 19 lecture hours.

PHCY 260, Cardiopulmonary Resuscitation CPR Elective Lecturer, 6 contact hours, 18 students


Tennessee Community Residents Program. Lecturer/Faciliator. 7 residents statewide. 2

lecture hours. 11.13.13 2012-2013 The University of Tennessee College of Pharmacy



10

Cardiovascular Disease in Women (1 hour) Hypertension (4 hours)


CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 1 student Fall semester 2012 (Molly Kinsella)

PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 18 students. 19 lecture hours.

PHCY 260, Cardiopulmonary Resuscitation CPR Elective Lecturer, 6 contact hours, 18 students

PHCY 257, Top 200 Elective. Lecturer, 1.5 student contact hours, 18 students Lecture topic: Cardiology Resident Teaching and Learning Certificate Program. Lecturer. 60 residents statewide. 2 lecture hours.

Tennessee Community Residents Program. Lecturer. 10 residents statewide. 2 lecture

hours. 2011-2012 The University of Tennessee College of Pharmacy

PHCY 211, Therapeutics I , Lecturer, 7 student contact hours, 150 students Lecture topics: Primary Prevention of Heart Disease (2 hours) Cardiovascular Disease in Women (1 hour) Hypertension (4 hours)


CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 1 student Fall semester 2011 (Jacob Marler)

CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 6 students; 2 contact hours per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D.

PHCY 355, Cardiology Elective, Course Co-coordinator and lecturer, 2 credit hour course., 15 students. 12 Lecture hours: Clinical Pharmacy in Cardiology Overview and Introduction, Valvular Heart Disease, Percutaneous Coronary Intervention, Advanced Cardiac Life Support and Arrhythmias, ECGs and Rhythm Recognition, Cardiology Pharmacotherapy Case Review PHCY 222, Therapeutics IV, Lecturer, 2 student contact hours, 158 students Lecture topic: Obesity and Cardiometabolic Complications (2 hours)


11

PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 18 students. 19 lecture hours.

PHCY 257, Top 200 Elective. Lecturer, 1.5 student contact hours, 18 students Lecture topic: Cardiology II PHCY 260, Cardiopulmonary Resuscitation CPR Elective

Lecturer, 6 contact hours, 18 students

St. George’s Medical School BIOE 501, Visiting Professorship, Contributing facilitator in the course “Bioethics and the Professional”. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 30-September 10th, 2011. 16 student contact hours; 72 students (6 groups of 12 students).


PHCY 211, Therapeutics I, Lecturer, 7 student contact hours, 158 students Lecture topics: Primary Prevention of Heart Disease (2 hours) Cardiovascular Disease in Women (1 hour) Hypertension (4 hours)

PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis. PHCY 222, Therapeutics IV, Lecturer, 2 student contact hours, 158 students Lecture topic: Obesity and Cardiometabolic Complications (2 hours) PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 15 students. 21 lecture hours. CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 15 student contact hours, 1 student Fall semester 2010 (Johanna Norman) PHCY 355, Cardiology Elective, Course Co-coordinator and lecturer, 2 credit hour course., 14 students. 10 Lecture hours: Clinical Pharmacy in Cardiology Overview and Introduction, Valvular Heart Disease, Percutaneous Coronary Intervention, Advanced Cardiac Life Support and Arrhythmias, ECGs and Rhythm Recognition CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 5 students; 2 contact hours per week. Shared group with Robbie Parker, Pharm.D. and


12

Kelly Rogers, Pharm.D. PHCY 122, Introduction to Patient Care, small group recitation leader, Fall semester. 4 students; 1 contact hour per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D. PHCY 260, Cardiopulmonary Resuscitation CPR Elective

Lecturer, 6 contact hours, 18 students Lincoln Memorial University DO SYS 753, Cardiovascular Pharmacology, Lecturer. Fall semester. 2 student contact hour;s 149 students. Lecture topic: Antihypertensive pharmacology. St. George’s Medical School BIOE 501, Visiting Professorship, Contributing facilitator in the course “Bioethics and the Professional”. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 24-September 4th, 2010. 16 student contact hours; 72 students (8 groups of 9 students).


PHCY 211, Therapeutics I , Lecturer, 7 student contact hours, 200 students Lecture topics: Primary Prevention of Heart Disease (2 hours) Cardiovascular Disease in Women (1 hour) Anticoagulation Issues in Percutaneous Coronary Intervention (1 hour) Hypertension (4 hours)

PHCY 222, Therapeutics IV, Lecturer, 2 student contact hours, 200 students Lecture topic: Obesity and Cardiometabolic Complications (2 hours) PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 16 students. 30 lecture hours. PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis. CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 2 students: 1 student Fall semester 2009 (Johanna Norman); 1 student Spring semester 2010 (Johanna Norman) PHCY 355, Cardiology Elective, Course Co-coordinator and lecturer, 2 credit hour course., 13 students. 10 Lecture hours: Clinical Pharmacy in Cardiology Overview and Introduction, Valvular Heart Disease, Percutaneous Coronary Intervention, Advanced Cardiac Life Support and Arrhythmias, ECGs and Rhythm Recognition


13

CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 4 students; 2 contact hours per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D.

CLPH 323, Applied Therapeutics, small group recitation leader, Spring semester 5 students; 2 contact hours per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D.

PHCY 122, Introduction to Patient Care, small group recitation leader, Spring semester.

5 students; 1 contact hour per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D.

PHCY 369, Lifestyle Management Elective, lecturer. Job-sharing. 1 student contact hour,

25 students Lincoln Memorial University DO SYS 753, Cardiovascular Pharmacology, Lecturer. Fall semester. 2 student contact hours; 149 students. Lecture topic: Antihypertensive pharmacology. Lecturer for Internal Medicine Grand Rounds, 1 lecture hour. Topic: Hypertensive Case Study.

University of Tennessee College of Medicine Lecturer for CV Fellows Lecture Series, 1 lecture hour. Topics: Updates in the Treatment for Cardiovascular Disease in the Elderly. Lecturer for Internal Medicine Grand Rounds, 2 lecture hours. Topics: Cardiovascular Disease in Women and Obesity and its Medical Complications



Lecture topics: Primary Prevention of Heart Disease (2 hours) Cardiovascular Disease in Women (1 hour) Anticoagulation Issues in Percutaneous Coronary Intervention (1 hour) Hypertension (4 hours) PHCY 222, Therapeutics IV, Lecturer, 3 student contact hours, 200 students Lecture topic: Obesity and Cardiometabolic Complications (3 hours)

CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 credit hour course. 2 students: 1 student Fall semester 2008 (Sarah Mizne); 1 student Spring semester 2009 (Sarah Mizne)


14

PHCY 355, Cardiology Elective, Course Co-coordinator and lecturer, 2 credit hour course., 14 students. 10 Lecture hours: Clinical Pharmacy in Cardiology Overview and Introduction, Valvular Heart Disease, Percutaneous Coronary Intervention, Advanced Cardiac Life Support and Arrhythmias, Clinical Controversies in Cardiology PHCY 366, Advanced Cardiac Life Support elective. Course Co-coordinator and lecturer, 2 credit hour course, 11 students. PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 5 students; 2 contact hours per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D.


PHCY 122, Introduction to Patient Care, small group recitation leader, Spring semester.


PHCY 360, Comprehensive Therapeutics Elective, lecturer. 0.5 student contact hours, 200 students. St. George’s Medical School BIOE 501, Visiting Professorship, Contributing facilitator in the course “Bioethics and the Professional”. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 26-September 6th, 2008. 16 student contact hours; 80 students (8 groups of 10 students). Lincoln Memorial University DO SYS 753, Cardiovascular Pharmacology, Lecturer. Fall semester. 1 student contact hour; 149 students. Lecture topic: Antihypertensive pharmacology. University of Tennessee College of Medicine Lecturer for CV Fellows Lecture Series, 5 lecture hours. Topics: Cardiometabolic Risk and the Endocannabinoid System, Pleiotropic Effects of Statins, Cardiovascular Disease in Women, and Cardiovascular Research Projects Lecturer for Internal Medicine Grand Rounds, 2 lecture hours. Topics: Cardiovascular Disease in Women and Obesity and its Medical Complications


15


PHCY 211, Therapeutics I , Lecturer, 8.5 student contact hours, 200 students

Lecture topics: Primary Prevention of Heart Disease (2 hours) Cardiovascular Disease in Women (1 hour)

Anticoagulation Issues in Percutaneous Coronary Intervention (1.5 hours) Hypertension (4 hours)

PHCY 222, Therapeutics IV, Lecturer, 3 student contact hours, 200 students Lecture topic: Obesity and Cardiometabolic Complications (3 hours) CLPH 240, Special Problems in Cardiology, Course Co-coordinator, 2 semester hour course. 3 students: Fall Semester 2007 (Kacie Smith and Ryan Parker) Spring semester 2008 (Sarah Mizne) PHCY 355, Cardiology Elective, Course Co-coordinator and lecturer, 2 credit hour course., 13 students. 10 lecture hours: Clinical Pharmacy in Cardiology Overview and Introduction, Valvular Heart Disease, Percutaneous Coronary Intervention, Advanced Cardiac Life Support and Arrhythmias, Clinical Controversies in Cardiology

PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 5 students; 2 contact hours per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D.


PHCY 122, Introduction to Patient Care, small group recitation leader, Spring semester


PPPE 213, Introduction to Patient Care, small group recitation leader. 5 students; 1 contact hour per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D. University of Tennessee College of Medicine Lecturer for CV Fellows Lecture Series, 5 lecture hours. Topics: Cardiometabolic Risk and the Endocannabinoid System, Pleiotropic Effects of Statins, Cardiovascular Disease in Women, and Hypertension Update


16

Lecturer for Internal Medicine Grand Rounds, 2 lecture hours. Topics: Cardiovascular Disease in Women and Obesity and it’s Medical Complications

2006-2007 The University of Tennessee College of Pharmacy PHCY 211, Therapeutics I , Lecturer, 8 student contact hours, 200 students

Lecture topics: Primary Prevention of Heart Disease (2 hours) Cardiovascular Disease in Women (2 hours) Anticoagulation Issues in Percutaneous Coronary Intervention (1 hour) Hypertension (4 hours)

PHCY 222, Therapeutics IV, Lecturer, 2 student contact hours, 200 students Lecture topic: Obesity and Cardiometabolic Complications (2 hours)

PHCY 355, Cardiology Elective, Course Co-coordinator and lecturer, 2 credit hour course., 13 students. 10 lecture hours: Clinical Pharmacy in Cardiology Overview and Introduction, Valvular Heart Disease, Percutaneous Coronary Intervention, Advanced Cardiac Life Support and Arrhythmias, Clinical Controversies in Cardiology

PHCY410.1, Cardiology Clinical Clerkship (shared rotation with Kelly Rogers, Pharm.D.), 4 credit hours, 12 students. VA Medical Center, Memphis. PHY 213, Patient Assessment, lab group instruction and lecturer, 2 student contact hours, 200 students. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 5 students; 2 contact hours per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D.




PPPE 213, Introduction to Patient Care, small group recitation leader.

5 students; 1 contact hour per week. Shared group with Robbie Parker, Pharm.D. and Kelly Rogers, Pharm.D. University of Tennessee College of Medicine

Lecturer for CV Fellows Lecture Series, 2 lecture hours. Topics: Cardiometabolic Risk and the Endocannabinoid System, Pleiotropic Effects of Statins


17

Lecturer for Internal Medicine Grand Rounds, 1 lecture hour. Topics: Cardiometabolic Risk and the Endocannabinoid System



Anticoagulation Issues in Percutaneous Coronary Intervention (1 hour)

PHCY410.1, Cardiology Clinical Clerkship, 4 credit hours, 20-30 contact hours per week, 2 students. Baptist Memorial Hospital, Memphis. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 5 students; 2 contact hours per week.

CLPH 323, Applied Therapeutics, small group recitation leader, Spring semester 5 students; 2 contact hours per week.


5 students; 1 contact hour per week.

PPPE 213, Introduction to Patient Care, small group recitation leader. 5 students; 1 contact hour per week.



Anticoagulation Issues in Percutaneous Coronary Intervention (1 hour)

PHCY410.1, Cardiology Clinical Clerkship, 4 credit hours, 20-30 contact hours per week, 10 students. Baptist Memorial Hospital, Memphis. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 5 students; 2 contact hours per week.

CLPH 323, Applied Therapeutics, small group recitation leader, Spring semester 5 students; 2 contact hours per week.


5 students; 1 contact hour per week.

PPPE 213, Introduction to Patient Care, small group recitation leader. 5 students; 1 contact hour per week. University of Mississippi School of Pharmacy


18

Cardiology Clinical Rotation 4 credit hours, 20-30 student contact hours per week (6 week rotation), 4 students. Baptist Memorial Hospital, Memphis.


PHCY 211, Therapeutics I , Lecturer, 2 student contact hours, 100 students Lecture topic: Primary Prevention of Heart Disease (2 hours)

PHCY410.1, Cardiology Clinical Clerkship, 4 credit hours, 20-30 contact hours per week, 6 students; 2 additional shared students with Dr. Kelly Rogers. Baptist Memorial Hospital, Memphis.

CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 4-6 students; 2 contact hours per week.

CLPH 323, Applied Therapeutics, small group recitation leader, Spring semester 4-6 students; 2 contact hours per week. University of Mississippi School of Pharmacy




Lecture topic: Primary Prevention of Heart Disease (2 hours)

PHCY410.1, Cardiology Clinical Clerkship, 4 credit hours, 20-30 contact hours per week, 3 students. Baptist Memorial Hospital, Memphis. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 4-6 students; 2 contact hours per week.





19


Lecture topic: Primary Prevention of Heart Disease (2 hours)

PHCY410.1, Cardiology/General Medicine Clinical Clerkship, 4 credit hours, 30-40 contact hours per week, 3 students. Baptist Memorial Hospital, Memphis. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 4-6 students; 2 contact hours per week.




PHCY 211, Therapeutics I , Lecturer, 2 student contact hours, 100 students Lecture topic: Primary Prevention of Heart Disease (2 hours)

PHCY410.1, Cardiology/General Medicine Clinical Clerkship, 4 credit hours, 30-40 contact hours per week, 2 students. Baptist Memorial Hospital, Memphis. CLPH 314, Applied Therapeutics, small group recitation leader, Fall semester 4-6 students; 2 contact hours per week.

CLPH 323, Applied Therapeutics, small group recitation leader, Spring semester 4-6 students; 2 contact hours per week.

University of Mississippi School of Pharmacy

Cardiology Clinical Rotation 4 credit hours, 30-40 student contact hours per week (6 week rotation), 1 student. Baptist Memorial Hospital, Memphis.

Baptist College of Health Sciences

Lecturer for pharmacology course to nursing students, 2 student contact hours, 15 students. Coordinator: Bryan Love, Pharm.D., BCPS

1999-2000 University of Memphis Loewenberg School of Nursing

Lecturer for pharmacology course to nursing students. Coordinator: Bob Lobo, Pharm.D., BCPS. Fall semester.


20

State Technical Institute Instructor, pharmacology course for medical transcription students. Spring semester 1999. 16 student contact hours, 15 students.

VISITING PROFESSORSHIPS

Contributing facilitator in the course BIOE 501, Bioethics and the Professional. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 12-August 24, 2016. 16 student contact hours; 80 students (8 groups of 10 students). Contributing facilitator in the course BIOE 501, Bioethics and the Professional. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 12-August 24, 2013. 16 student contact hours; 80 students (8 groups of 10 students). Contributing facilitator in the course BIOE 501, Bioethics and the Professional. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 29-September 10th, 2011. 16 student contact hours; 80 students (8 groups of 10 students). Contributing facilitator in the course BIOE 501, Bioethics and the Professional. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 24-September 4th, 2010. 16 student contact hours; 72 students (8 groups of 9 students). Contributing facilitator in the course BIOE 501, Bioethics and the Professional. St. George’s University Medical School. St. Georges, Grenada (West Indies). August 26-September 6th, 2008. 16 student contact hours; 80 students (8 groups of 10 students).

INVITED LECTURES International

1. A Case of Dyspnea. Grand Rounds presented with Dr. Lloyd Finks to Clinical Tutors at St. George’s University Medical School. Grenada, West Indies. August 15, 2013.

2. Ethical and Legal Implications of Off-Label Prescribing Presented with Dr. Lloyd Finks to Clinical Tutors Grand Rounds at St. George’s University Medical School. Grenada, West Indies. August 11, 2016.

National

3. Moderator for the session "Pharmacotherapy of Metabolic Syndrome: What Does the Future


21

Hold?". Presented at ACCP 2006 Annual Meeting. America’s Center Convention Center. St. Louis, MO. October 29, 2006.

4. Differences in Therapeutic Guidelines between Men and Women. Presented at the ACCP Annual Meeting Cardiology PRN Focus Session—Battle of the Sexes: Addressing Gender-Specific Differences in Cardiovascular Disease. ACPE # 217-000-08-114-L01-P. ACCP 2008 Annual Meeting, Louisville, Kentucky. October 21, 2008.

5. To bridge or not to bridge for patients with AF: Con Side Presented at the ACCP Annual Meeting Cardiology PRN Focus Session-- De-mystifying arrhythmias: Everyday tools for the Pharmacist. ACPE # 217-0000-10-129-L01-P. ACCP 2010 Annual Meeting, Austin, Texas. October 19th, 2010.

6. Cardiology II Presented at ACCP Updates in Therapeutics 2012®: The Pharmacotherapy Preparatory Review and Recertification Course. ACPE # 0217-0000-12-026-L01, 1 contact hour. Reno, NV. May 1, 2012.

7. Cardiology Presented online for ACCP’s Last Chance Pharmacotherapy Review Webinar 2012. September 5, 2012.

8. First Do No Harm: Proven and Possible Adverse Effects of Complementary and Alternative

Medicines Presented at The American Heart Association Scientific Sessions 2012. In Session: Demystifying Complementary and Alternative Medicine in Prevention of Cardiovascular Disease. Los Angeles, California. November 7, 2012.

9. Cardiology I Presented at ACCP Updates in Therapeutics® 2013: The Pharmacotherapy Preparatory Review and Recertification Course. ACPE # 0217-0000-13-029-L01-P. 1.5 contact hours. Reno, NV. April 23, 2013. In addition, lectures were recorded for online home study. Activity No. 0217-0000-13-029-H01-P; 1.5 contact hours.

10. Moderator for Cardiology I and II. Presented at ACCP Updates in Therapeutics® 2013: The Pharmacotherapy Preparatory Review and Recertification Course. Reno, NV. April 23, 2013.

11. Cardiology Presented online for ACCP’s Last Chance Pharmacotherapy Review Webinar 2013. ACPE# 0217-0000-13-154-L01-P, 1 contact hour. Application-based activity. September 4, 2013.

12. Heart Failure Drugs in Pregnancy: What is Safe? Presenter in Clinical Fundamentals III: The Pregnant Patient with Heart Failure at the 17th Annual Heart Failure Society of America. ACPE# 0008-9999-13-068-L01-P, 1.5 contact hours. Orlando, Florida. September 25th, 2013. Approximately 200 attendees.

13. Cardiology I: Updates for the Ambulatory Care Pharmacist Presented online for ACCP’s Last Chance Pharmacotherapy Review Webinar Series® 2014. ACPE# 0217-0000-14-052-L01-P, 1 contact hour. Application-based activity. February 26, 2014. Approximately 40 attendees.


22

14. Cardiology I: Updates for the Pharmacotherapy Specialist

Presented online for ACCP’s Last Chance Pharmacotherapy Review Webinar Series® 2014. ACPE# 0217-0000-14-051-L01-P, 1 contact hour. Application-based activity. February 25, 2014. Approximately 120 attendees.

15. Cardiology I Presented at ACCP Updates in Therapeutics® 2014: The Pharmacotherapy Preparatory Review and Recertification Course. Activity No. 0217-0000-14-029-L01-P ; 1.5 contact hours. Rosemont, Illinois. April 15, 2014. Approximately 575 attendees. In addition, lectures were recorded for online home study. Activity No. 0217-0000-14-029-H01-P; 1.5 contact hours.

16. Moderator for Cardiology I and II. Presented at ACCP Updates in Therapeutics® 2014: The Pharmacotherapy Preparatory Review and Recertification Course. Rosemont, Illinois. April 15, 2014.

17. Cardiology Presented online for ACCP’s Last Chance Pharmacotherapy Review Webinar 2014. ACPE# 0217-0000-14-157-L01-P, 1 contact hour. Application-based activity. September 3, 2014. Approximately 200 attendees.

18. Moderator for “Continuity of Cardiovascular Care: Considering Inpatient and Outpatient Perspectives for Heart Failure, Valve Disease, and Uncontrolled Cardiovascular Risk”. Presented at 2014 ACCP Annual Meeting. Austin, Texas. October 14, 2014.

19. Updates in Cardiology Presented online for ACCP’s Updates Plus in Pharmacotherapy Webinar 2015. Activity No. 0217-0000-15-065-H01-P, 2.0 contact hours. Application-based activity. February 25, 2015. Approximately 40 attendees.

20. Cardiology I Presented at ACCP Updates in Therapeutics® 2015: The Pharmacotherapy Preparatory Review and Recertification Course. Activity No. 0217-0000-15-020-L01-P; 1.5 contact hours. Rosemont, Illinois. April 13, 2015. Approximately 400 attendees. In addition, lectures were recorded for online home study. Activity No. 0217-0000-15-020-H01-P; 1.5 contact hours.

21. Moderator for Cardiology I and II. Presented at ACCP Updates in Therapeutics® 2015: The Pharmacotherapy Preparatory Review and Recertification Course. Rosemont, Illinois. April 13, 2015.

22. Benefits and Challenges of Peer-Reviewing Test Items by Committee Presented with Sharon McDonough, PhD at the Association for the Assessment of Learning in Higher Education (AALHE) 2015 conference in Lexington, Kentucky. June 2, 2015.

23. Cardiology Presented online for ACCP’s Last Chance Pharmacotherapy Review Webinar 2015. ACPE# 0217-0000-15-169-L01-P; 3.0 contact hours. Application-based activity. September 1, 2015. Approximately 80 attendees.

24. Pharmacologic Options and Drug Selection Considerations for the Prevention of Thrombotic


23

Cardiovascular Events Presented online with live question and answer session for FreeCE.com webinar series. ACPE# 0798-0000-15-141-L01, 1.0 contact hours. Application-based activity. Offered on: November 11, 2015, with 1003 online attendees December 3, 2015, with 1000 online attendees December 15, 2015, with 559 online attendees January 7, 2016, with 609 online attendees February 19, 2016 with 998 online attendees March 2, 2016 with 833 online attendees March 22, 2016 with 483 online attendees April 6, 2016 with 573 online attendees May 11, 2016 with 678 online attendees June 28, 2016 with 554 online attendees July 28, 2016 with 526 online attendees

25. Updates in Cardiology 2016 Presented online for ACCP’s Updates in Pharmacotherapy Webinar 2016. Activity No. 0217-0000-16-077-H01-P. Application based activity. February 23,2016. Approximately 40 attendees.

26. Moderator for Cardiology I and II and Men and Women’s Health. Presented at ACCP Updates in Therapeutics® 2016: The Pharmacotherapy Preparatory Review and Recertification Course. Phoenix, Arizona. April 10, 2016.

27. Cardiology I Presented at ACCP Updates in Therapeutics® 2016: The Pharmacotherapy Preparatory Review and Recertification Course. Activity No. 0217-0000-16-034-L01-P; 1.5 contact hours. Phoenix, Arizona. April 10, 2016. Approximately 400 attendees. In addition, lectures were recorded for online home study. Activity No. 0217-0000-16-034-H01-P; 1.5 contact hours

28. Broken Hearts: Chronic Heart Failure- Optimizing Treatment, Avoiding hospitalization Presented online with live question and answer session for FreeCE.com webinar series. ACPE# 0798-0000-16-043-L01, 1.25 contact hours. Application-based activity. Offered on: June 1, 2016 with 1026 online attendees July 25, 2016 with 835 online attendees August 30, 2016 with 834 online attendees November 3, 2016 with 545 online attendees December 16, 2016 with 791 online attendees

29. Cardiology Presented online for ACCP’s Last Chance Pharmacotherapy Review Webinar 2016. ACPE# 0217-0000-16-181-L01-P; 3.0 contact hours. Application-based activity. September 7, 2016. Approximately 40 attendees.

30. Cardiology I Presented at ACCP Updates in Therapeutics® 2017: The Pharmacotherapy Preparatory Review and Recertification Course. Activity No. 0217-0000-17-053-L01-P ; 1.5 contact hours. Jacksonville, Florida. February 19, 2017. Approximately 350 attendees. In addition, lectures


24

were recorded for online home study. Activity No. 0217-0000-17-053-H01-P; 1.5 contact hours.

31. Moderator for Cardiology I and II and Oncology Supportive Care. Presented at ACCP Updates in Therapeutics® 2017: The Pharmacotherapy Preparatory Review and Recertification Course. Jacksonville, Florida. February 19, 2017.

32. Cardiology I Presented at ACCP Updates in Therapeutics® 2018: The Pharmacotherapy Preparatory Review and Recertification Course. Activity No. 0217-0000-18-054-L01-P; 1.5 contact hours. Jacksonville, Florida. February 18, 2018. Approximately 350 attendees. In addition, lectures were recorded for online home study. Activity No. 0217-0000-18-054-H01-P; 1.5 contact hours.

33. Moderator for Cardiology I and II and Oncology Supportive Care. Presented at ACCP Updates in Therapeutics® 2017: The Pharmacotherapy Preparatory Review and Recertification Course. Jacksonville, Florida. February 18, 2018.

34. Acute Coronary Syndrome Presented at ACCP Updates in Therapeutics® 2018: The Cardiology Pharmacy Preparatory Review Course. Activity No. 0217-0000-18-062-L01-P; 1.5 contact hours. Jacksonville, Florida. February 18, 2018. Approximately 40 attendees. In addition, lectures were recorded for online home study. Activity No. 0217-0000-18-062-H01-P; 1.5 contact hours.

35. Cardiology Presented at ACCP Updates in Therapeutics® 2018: The Pharmacotherapy Preparatory Review and Recertification Course. Activity No. 0217-0000-18-121-L01-P; 1.5 contact hours. Pamona, California. April 21, 2018. Approximately 50 attendees.

36. Acute Coronary Syndrome Presented at ACCP Updates in Therapeutics® 2018: The Cardiology Pharmacy Preparatory Review Course. Activity No. 0217-0000-18-126-L01-P; 1.5 contact hours. Pamona, California. April 22, 2018. Approximately 35 attendees.

37. Moderator for Cardiology, Critical Care and Pulmonary Disorders. Presented at ACCP Updates in Therapeutics® 2018: The Pharmacotherapy Preparatory Review and Recertification Course. Pamona, California. April 21, 2018.

38. Gotta Catch Them All! The Pokemon Approach to Understanding Direct Oral Anticoagulants. Presented online with live question and answer session for FreeCE.com webinar series. ACPE# 0798-0000-18-046-L01-P, 1.00 contact hours. Application-based activity. Offered on: March 27, 2018 with 796 online attendees April 26, 2018 with 858 online attendees May 16, 2018 with 804 online attendees June 26, 2018 with 640 online attendees July 26, 2018 with 627 online attendees August 26, 2018 with 380 online attendees October 16, 2018 with 503 online attendees


25

39. Nontraditional Work Arrangements: A Road Less Traveled in Pharmacy Academia

Presented at AACP 2018 Annual Meeting. ACPE# 0581-0000-18-095-L04-P; 1.5 contact hours. Boston, Massachusetts. July 24, 2018.

40. Another Broken Heart; Understanding and Treating Heart Failure Presented online with live question and answer session for FreeCE.com webinar series. ACPE# 0798-0000-18-111-L01-P, 1.5 contact hours. Application-based activity. Offered on: August 27, 2018 with 994 online attendees September 24, 2018 with 863 online attendees October 26, 2018 with 1050 online attendees

Region

41. Treatment of Pelvic Inflammatory Disease in the Emergency Department: An Analysis of Appropriateness and Cost Resident Project presented at Mid-West Residency Conference. St. Louis, Missouri. April 17, 1999.

42. Advances in Therapy with IV Amiodarone

Presented to critical care nurses at the Greater Memphis Area Chapter of AACN. CEUs approved through CH AACN Provider. Memphis, Tennessee. July 5, 2000.

43. Drug Therapy in Acute Coronary Syndromes Presented to the AACN group of the Southeast region. CEUs approved through CH AACN Provider. St. Frances Hospital, Memphis, Tennessee. October 19th, 2001.

44. I wish there was a Magic Pill: The Pharmacists Role in the Treatment of Obesity Presented to Middle Tennessee area Kroger Pharmacists. ACPE credit awarded. Nashville, Tennessee, June 24, 2001.

45. Drug Therapy in Acute Coronary Syndromes Presented to The Southeast Regional Cardiovascular Health Conference. Renaissance Hotel. CEUs, ACPE, and CME awarded for MD, RN, RD, CHES (certified health education specialists), RPh, case managers, and social workers. Nashville, Tennessee. September 11th, 2001.

46. Management of Obesity: What every practitioner needs to know Presented with Dr. Lloyd Finks, MD at the AACN group of the Southeast region. CEUs approved through CH AACN Provider. St. Frances Hospital, Memphis, Tennessee. February 28th, 2003.

47. Optimal Drug Therapy in Heart Failure Presented with Dr. Lloyd Finks, MD at the Heart Failure Conference to healthcare providers. Terrace Hotel, Tunica, Mississippi. 0.1 CEU granted for nursing. March 1, 2003.


26

48. Anticoagulation in Percutaneous Coronary Intervention Presented with Dr. Kelly Rogers, PharmD, at the Southeastern College of Anticoagulation Providers conference. ACPE # 064-000-03-063-L01. Franklin, Tennessee. September 13th, 2003.

49. Anticoagulation Issues in Percutaneous Coronary Intervention Presented with Dr. Kelly Rogers, PharmD, at the AACN Greater Memphis Area Chapter Spring Seminar. Memphis, Tennessee. CEUs approved through CH AACN Provider #10806. March 26, 2004.

50. Obesity and Cardiometabolic Risk Presented to the 125th Arkansas Pharmacists Association Annual Convention. ACPE # 004-999-07-015-L01. Embassy Suites Convention Center. Rogers, Arkansas. June 14th, 2007.

51. A Woman’s Heart: A Focus on Cardiovascular Disease in Women Presented to the Arkansas Pharmacists Association Women’s Conference. ACPE # 004-999-07-053-L01-P. Chatteau on the Lake. Branson, Missouri. November 7th, 2007.

52. Hypertension Update with Special Focus on the Female Patient Presented to the Arkansas Pharmacists Association Women’s Conference. ACPE # 004-999-07-055-L01-P. Chatteau on the Lake. Branson, Missouri. November 9th, 2007.

53. An Introduction to Cardiology Clinical Pharmacy and Academia Presented to the Pre-Pharmacy Professional Group of West Tennessee. University of Tennessee Health Science Center. September 30th, 2010.

54. Updates in Acute Coronary Syndrome Guidelines and Practice Presented at the 60th Annual Meeting of the Mississippi Society of Health-System Pharmacists Diamond Jubilee. ACPE # 0032-9999-13-057-L01-P. The Hilton Garden Inn. Jackson, Mississippi. July 27th, 2013.

55. Writing the Defensible Test Question Presented to faculty and staff at Butler University as a part of their Faculty Enrichment Series. Butler University College of Pharmacy and Health Sciences. Indianapolis, Indiana. October 9, 2013.

State

56. The Changing ACLS Guidelines

Presented to Jackson General Department of Education CME Association. CME for one (1) credit hour in Category 1 toward the Physician’s Recognition Award of the American Medical Association Jackson, Tennessee. November 16th, 2000.

57. Advances in Treating Ventricular Tachyarrhythmias: the new ACLS guidelines Presented to Jackson General Department of Education CME Association at Grand Rounds. CME for one (1) credit hour in Category 1 toward the Physician’s Recognition Award of the American Medical Association. Jackson, Tennessee. March 13, 2001.

58. Advances in Treating the Patient With Congestive Heart Failure Presented in Workshop Forum to Attendees at Tennessee Society of Health-System Pharmacists


27

Thirtieth Annual Meeting. ACPE # 064-000-01-109-L01. Nashville, Tennessee. April 7, 2001.

59. A Fresh Approach to the Management of Obesity Presented with Dr. Lloyd Finks, MD at the 114th Annual Tennessee Pharmacist Association Meeting. ACPE # 217-999-01-089-L01. Chattanooga Convention Center. Chattanooga, Tennessee. July 25th, 2001.

60. A Fresh Approach to Obesity Management Presented with Dr. Lloyd Finks, MD at the Mid South College of Clinical Pharmacy Fall Meeting. ACPE # 217-999-01-089-L01. Memphis, Tennessee, October 30th, 2001.

61. Heart Failure: The New Practice Guidelines Presented with Dr. Lloyd Finks, MD at the 32nd Annual Meeting of the Tennessee Society of Health-System Pharmacists. Nashville, Tennessee. ACPE# 064-000-02-101 through 121-L01. April 6th, 2002.

62. Primary Prevention of Heart Disease: Risk Factor Modification Presented at “If Hearts Could Talk, What Would They Tell Us” Cardiovascular Conference. Memphis, Tennessee. ACPE # 508-000-03-013-L01. Additional: TNA Contact hours, 0.1 CEU for nursing. October 10th, 2003.

63. The Primary Prevention of Cardiovascular Diseases Presented to the Mid-South College of Clinical Pharmacy. Memphis, Tennessee. ACPE #217-999-05-122-L01. September 22, 2005.

64. Two Heads Are Better Than One: Our Job Share Experience

Presented with Dr. Kelly Rogers. Department of Clinical Pharmacy Grand Rounds. University of Tennessee Health Science Center. Memphis, Tennessee. May 22, 2008.

65. Primary and Secondary Prevention of Coronary Heart Disease: 2008 CHEST Update.

Presented to clinical pharmacy members at Mid-South College of Clinical Pharmacy. Memphis, Tennessee. August 19, 2008.

66. Updates in the Treatment for Cardiovascular Disease in the Elderly Population Presented at the 2009 Geriatric and Long Term Care Conference, sponsored by the Tennesee Pharmacists Association’s Society of Long Term Care Pharmacists. ACPE# (1.5) 064-000-09-136-L01-P&T. Franklin, Tennessee. August 18, 2009.

67. Charge to the Class of 2010: Count, Dispense, and Care Invited graduation address to the Class of 2010 at the University of Tennessee College of Pharmacy Honors and Awards Convocation. First Baptist Church, Memphis, Tennessee. May 27th, 2010.

68. Updates in Cardiovascular Disease: The Pharmacist versus Physician Perspective Presented with Dr. A. Lloyd Finks, MD at the 2010 Tennessee Pharmacists Association Annual Convention. ACPE (2.0) # 064-000-10-119-L01-P. Memphis, Tennessee. July 21, 2010.

69. Updates and Guideline Changes in Basic Life Support and Advanced Cardiac Life Support Presented with Dr. Kelly Rogers at The University of Tennessee College of Pharmacy Grand Rounds. Memphis, Tennessee. April 21, 2011.


28

70. Hypertension: Considerations for Community Practice. Tennessee Community Pharmacy

Residency AV Conference. Presented over Mediasite technology to 4 statewide locations. Memphis, Tennessee. December 10, 2012.

71. Writing the Defensible Test Question. Presented to the Tennessee PGY-1 Residents as a part of the Resident Teaching and Learning Certificate Program. Presented live and over Mediasite technology to 3 statewide locations. Approximately 75 residents statewide. 2 Lecture hours. Memphis, Tennessee. January 27, 2014.

72. Interpreting Item Analysis and other exam statistics. Presented to faculty, staff, and guests at the University of Tennessee 2013 Faculty Retreat. Presented live and over Mediasite to 2 statewide locations. Memphis, Tennessee. May 28, 2013.

73. The ABCDs of Writing Quality Test Questions. Presented to faculty, staff, and guests at the University of Tennessee 2013 Faculty Retreat. Presented live and over Mediasite to 2 statewide locations. Memphis, Tennessee. May 27, 2013.

74. How to Write Good Test Questions. Presented to the Tennessee PGY-1 Residents as a part of the Resident Teaching and Learning Certificate Program. Presented live and over Mediasite technology to 3 statewide locations. Memphis, Tennessee. January 24, 2013.

75. New Guideline?: What JNC8 is NOT. Presented to faculty, staff, and guests at Grand Rounds at the University of Tennessee. Presented live and over Mediasite across statewide locations. Memphis, Tennessee. February 20th, 2014.

76. Cardiology Update

Presented to attendees as a part of the 2016 Fall Therapeutics Seminar at the University of Tennessee. Presented live across statewide locations. UAN: 0064-0000-16-074-L01-P&T, 3 contact hours. Chattanooga, Tennessee. September 16th, 2016. 87 Registrants. Memphis, Tennessee. October 7th, 2016. 100 Registrants. Franklin, Tennessee. October 14th, 2016. 120 Registrants. Knoxville, Tennessee. November 11th , 2016. 140 Registrants.

77. Pros, Cons, and Pokémon’s of Modern Anticoagulation Presented live to clinical pharmacy members at Mid-South College of Clinical Pharmacy. 1 hour ACPE # 0217-9999-17-130-L01-P. Memphis, Tennessee. July 11, 2017. 85 attendees.

78. Practical Management of Acute Coronary Syndrome

Presented live to clinical pharmacy members at Mid-South College of Clinical Pharmacy. 1 hour ACPE # 0217-9999-18-273-L01-P. Memphis, Tennessee. November 8, 2018. 85 attendees.

Local

79. Sexually Transmitted Disease

Lecture presented to University of Tennessee Pharm.D. Students. Memphis, Tennessee. April


29

5, 1999.

80. Integrilin in Acute Coronary Syndromes Presented to nurses at Baptist Memorial Hospital East. Memphis, Tennessee. November 5, 16, 17, 19, and 23, 2000.

81. ACLS Guideline Changes: a new approach in ventricular tachyarrhythmias Presented to physician audience. Memphis, Tennessee. December 18, 2000.

82. Ten Strategies for the Prevention of Heart Disease Presented to Fed-Ex Wellness Center open to all Fed-Ex employees. Memphis, Tennessee. Feb 23rd and 27th 2001

83. The New ACLS Guidelines Presented to the Stern Cardiovascular Center. Memphis, Tennessee. March 1, 2001.

84. Primary Prevention of Heart Disease: Risk Factor Modification ACPE Continuing Pharmacy Education presented to the Department of Pharmacy Services on Baptist East, Memphis, Tennessee. ACPE # 508-000-01-001-L01. March 15th and 22, 2001.

85. Advances in Treating Ventricular Tachyarrhythmias: the new ACLS guidelines Presented to UT Family Practice Residents at Noon Grand Rounds. Memphis, TN, March 30, 2001.

86. The new ACLS guidelines: a new approach

Presented Stern Cardiovascular nurse practitioners. Memphis, Tennessee, April 10, 2001.

87. Drug Therapy review in the new ACLS Guidelines Presented to the Stern Cardiovascular Center nurses at Stern Cardiovascular. Memphis, Tennessee. November 8th and 15th, 2001.

88. Emerging Risk Factors in Cardiovascular Disease: A closer look at Obesity, Inflammation, and

CVD Risk ACPE Staff Development Module presented to Baptist Memorial Health Care employees. Memphis, Tennessee. ACPE # 508-000-03-006-L01. May 20th and 21st, 2003.

89. Anticoagulation Surrounding PCI Presented at the Clinical Pharmacy Forum. Memphis, Tennessee. November 6th, 2003.

90. Anticoagulation Issues in Percutaneous Coronary Intervention Presented with Dr. Kelly Rogers, PharmD, at the Stern Cardiovascular Center. Coronary Artery Disease, Acute Coronary Syndrome and Coagulation—Understanding the New Model for Improving Patient Care 3 Course Series. 6 hours CEU credits through the Baptist College of Health Sciences and Tennessee Nurses Association. Memphis, Tennessee. January 27th, 2004.

91. Spotting the Telltale Signs of Heparin Induced Thrombocytopenia Presented at Grand Rounds to CV and CVICU nursing staff and pharmacists at Baptist Memorial Hospital Memphis. Memphis, Tennessee. March 16th, 2005.

92. Advanced Cardiac Life Support Pharmacology Lecture


30

Presented to Baptist Memorial Hospital Staff requiring ACLS updates. Memphis, Tennessee. June and July 2005.

93. The Primary Prevention of Cardiovascular Diseases Presented to Memphis Managed Care Corporation-TLC case managers, utilization managers, and disease specialists. CEU’s provided through Commission for Case Manager Certification #6117038608. December 9 and 11, 2005.

94. Primary and Secondary Prevention of Coronary Heart Disease. Presentation in A Selected Update of CHEST 2008. Presented to invited guests at Methodist University Hospital. Memphis, Tennessee. ACPE # 217-999-08-135-L01-P. November 6th, 2008.

95. Nutrition Interventions for Cardiovascular Disease: Hypertension, Heart Failure, and

Hyperlipidemia Presented with Anita Airee, Pharm.D. in the Rho Chi Nutrition Seminar Series at the University of Tennessee Health Science Center. Memphis, Tennessee. November 6th, 2008.

96. Cardiovascular Disease in Women Presentation at Pharmacotherapy Rounds. VA Medical Center, Memphis, Tennessee. February 9th, 2010.

97. To bridge or not to bridge for patients with AF Presented at Pharmacotherapy Grand Rounds. VA Medical Center, Memphis, Tennessee. August 18th, 2010.

98. Important Considerations with Newer Antiplatelet and Antithrombotic Agents Post PCI and in Atrial Fibrillation Presented to Memphis Area Pharmacists Society, Spring Meeting. 1.5 hours ACPE # 0064-0000-11-022-L01. Memphis, Tennessee. April 12th, 2011.

99. Important Considerations with Newer Antiplatelet and Antithrombotic Agents Presentation at Pharmacotherapy Rounds. VA Medical Center, Memphis, Tennessee. November 27th, 2012.

100. Important Considerations with Newer Antiplatelet and Antithrombotic Agents Invited presentation for Internal Medicine Grand Rounds. Presented live and over Mediasite technology to 2 hospital locations. UTHSC. Memphis, Tennessee. November 30th, 2012.

101. Acute Coronary Syndromes: Pharmacology and Practice Invited presentation for Internal Medicine Grand Rounds. Presented live and over Mediasite technology to 2 hospital locations. UTHSC. Memphis, Tennessee. November 22, 2013.

102. Acute Coronary Syndromes: What’s New in Guidelines and Practice Presented to Memphis Area Pharmacists Society, December Meeting. 1 hours ACPE # 0064-0000-13-152-L01-P. Memphis, Tennessee. December 5th, 2013.

103. The New JNC8 Hypertension Guidelines Presented to pharmacy staff and residents in Pharmacotherapy Rounds format. VA Medical Center, Memphis, Tennessee. March 18th, 2014.


31

104. A Modern look at Anticoagulation Presented live to Memphis area and VAMC Clinical Pharmacists during Pharmacotherapy Rounds. 1 hour ACPE # 0064-0000-17-056-L01-P. VA Medical Center, Memphis, Tennessee. August 1, 2017.

105. Managing Statin Adverse Events. Presented to pharmacy staff and residents in Pharmacotherapy Rounds format. VA Medical Center, Memphis, Tennessee. November 6, 2017.

Community:

106. Heart Health: Reducing Your Risk of Heart Disease Now

Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. October 15, 1999.

107. Understanding Your Heart Failure Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. November 19, 1999.

108. The Cold Hard Facts About those Nighttime Sniffling Sneezing Coughing Aching Stuffy-head Fever So You Can Rest Medicines Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. December 16, 1999.

109. Feel More Energetic! Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. February 21, 2000.

110. The Diet Craze of America Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. March 24, 2000.

111. Wise Tips for all Your Trips Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. April 7, 2000.

112. America’s Diet Craze Presented with Dr. A. Lloyd Finks, M.D. to Taking Off Pounds Sensibly (TOPS). Memphis, Tennessee. May 13, 2000.

113. Talking With Your Doctor: Making the most of your medical visit Presented with Dr. A. Lloyd Finks, M.D. to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. May 19, 2000.

114. Top Strategies for Preventing a Heart Attack Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee.


32

June 26, 2000.

115. Feel More Energetic! Presented to the public at Baptist Cancer Institute Life Center. Memphis, Tennessee. October 25, 2000.

116. What you can do to prevent Heart Disease Presented to Dana Corporation Employees at Clevite Engine Parts Plant. Collierville, Tennessee. July 19th, 2001. Olive Branch, Mississippi. July 23rd, 2001.

117. Mend My Heart: Getting the Most Benefit from Your Heart Medications Presented to “Mended Hearts”, a local heart patient group. St. Frances Hospital. Memphis, Tennessee. March 25th, 2010.

EDITORIAL APPOINTMENTS

American College of Clinical Pharmacy ACCP Flip Cards: Critical Care, Cardiology Reviewer

ACCP Flip Cards: Critical Care is an ACCP publication intended especially for pharmacy professionals preparing for the Critical Care Specialty Certification Examination. Designed for review on the go, 300 patient-centered, disease-specific vignettes and clinical scenarios are presented on durable flip cards conveniently arranged, tabbed, and color-coded by examination domain. As one of two reviewers for cardiology, I was responsible for reviewing, rewriting, and assessing the complexity of questions within the cardiology therapeutic area. This product is available for purchase from the ACCP bookstore since 2015.

ACCP Flip Cards: Pharmacotherapy, Cardiology Reviewer

ACCP Flip Cards: Pharmacotherapy is an ACCP publication intended especially for pharmacy professionals preparing for the Pharmacotherapy Specialty Certification Examination, as well as for Board Certified Pharmacotherapy Specialists seeking recertification by continuing education. Designed for review on the go, 300 patient-centered, disease-specific vignettes and clinical scenarios are presented on durable flip cards conveniently arranged, tabbed, and color-coded by examination domain. As one of two reviewers for cardiology, I was responsible for reviewing, rewriting, and assessing the complexity of questions within the cardiology therapeutic area. This product is available for purchase from the ACCP bookstore (since June 1, 2014).

American College of Clinical Pharmacy/Pharmacotherapy Self-Assessment Program Pharmacotherapy Self Assessment Program (PSAP) VII Editorial Board Member,

October 2009 to 2012


33

The goal of PSAP is to provide pertinent pharmacotherapeutic updates to enhance and assess the practice skills of pharmacists. Eleven books are published about every 3 months in 3-year cycles to provide continuing education credit for pharmacotherapy board recertification. The editorial board selects topics for the 11 chapters in each of the books, assures that the publication satisfies requirements of the Board of Pharmaceutical Specialties, and develops style criteria, considering survey results from subscribers. Each editorial board member reviews at least one chapter for each book (three drafts plus galleys). The first draft can require up to 16 hours of edit time, whereas subsequent drafts require approximately 8 and 2 hours, respectively. Each editorial board member also coordinates one book in the series. Authors and reviewers considered to be experts on the topic are recruited, each draft is reviewed to assure appropriate coverage of the topic and avoidance of content overlap in each chapter, and differences of opinion among authors and various reviewers are mediated.

Individual Chapters reviewed in PSAP VII: Farrington EA. Management of the Postoperative Patient After Congenital Heart Disease Repair. In: Richardson M, Chant C, Chessman KH, Finks SW, Hemstreet BA, Hume AL, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. PSAP VII, Book 4, Pediatrics III. Lenexa, KS: American College of Clinical Pharmacy, 2010:175-92. Hein BE, Pruemer, JM. Update on Erythropoietin Stimulating Agents in the Treatment of Anemia Associated with Chronic Kidney Disease and Cancer. In: Richardson M, Chant C, Chessman KH, Finks SW, Hemstreet BA, Hume AL, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. PSAP VII, Book 5, Chronic Illnesses III. Lenexa, KS: American College of Clinical Pharmacy, 2010:235-52. Ho VQ. Non-Hodgkin Lymphoma. In: Richardson M, Chant C, Chessman KH, Finks SW, Hemstreet BA, Hume AL, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. PSAP VII, Book 6, Oncology III. Lenexa, KS: American College of Clinical Pharmacy, 2011:149-59. Cook K, Dobesh PP. Cardiovascular Disease in Older Adults. In: Richardson M, Chant C, Chessman KH, Finks SW, Hemstreet BA, Hume AL, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. PSAP VII, Book 7, Geriatrics I. Lenexa, KS: American College of Clinical Pharmacy, 2012:27-48. Kavookjian, Jan. Motivational Inteviewing. In Richardson M, Chant C, Chessman KH, Finks SW, Hemstreet BA, Hume AL, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. PSAP VII, Book 8, Science and Practice of Pharmacotherapy I. Lenexa, KS: American College of Clinical Pharmacy, 2012:1-18. See S. GERD. In: In Richardson M, Chant C, Chessman KH, Finks SW, Hemstreet BA, Hume AL, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. PSAP VII, Book 11. GI. Lenexa, KS: American College of Clinical Pharmacy, 2012:109-23.

American Journal of Medicine Specialty Editor Commissioned articles include:

Rogers KC, Finks SW. A New Option for Reversing the Anticoagulant Effect of Factor Xa


34

Inhibitors: Andexanet alfa (Andexxa®). Am J Med. 2018. Submitted June 2018. Dobesh PP. Betrixaban: what this DOAC can offer for VTE prophylaxis. Am J Med. 2018. In press. Atkinson TJ. Ketamine: an old friend with a new indication. Am J Med. 2018. Epub ahead of print. George CM, Byun A, Howard-Thompson A. New injectable agents for the treatment of type 2 diabetes part 1-injectable insulins. Am J Med 2018; epub ahead of print. Self TH, Ellington S. New treatment option for chronic obstructive pulmonary disease: two long-acting bronchodilators in a single metered-dose inhaler. Am J Med. 2017;130(11):1251-54. Gibson CM, Finks SW. Edoxaban: how does the newest agent fit into the DOAC landscape? Am J Med. 2017;130(8):900-6. Rodgers JE. Sacubitril/Valsartan: The newest addition to the toolbox for guideline-directed medical therapy of heart failure. Am J Med. 2017;130(6):635-9.

Finks SW, Rogers KC. Idarucizumab (Praxbind): The first reversal agent for a direct oral anticoagulant. Am J. Med 2017;130(5):e195-e197.

COMMITTEES AND OFFICES HELD

National American College of Clinical Pharmacy

Cardiology Preparatory Review and Recertification Course Planning Committee, 2017 Cardiology PRN Research and Scholarship Committee, Member 2016-2017 Work Group on Pharmacotherapy Curriculum Didactic Toolkit, member 2016 For the 2015-16 AACP Educational Affairs Committee Vice Chair, ACCP Public and Professional Relations Committee, 2015-2016 Cardiology PRN Research and Scholarship Committee, Member 2015-2016 Pharmacotherapy Preparatory Review and Recertification Course Planning Committee,

2015, 2016, 2017, 2018 Chair, Nominations Committee, Cardiology Practice Research Network 2014-15 Chair, Cardiology Practice Research Network 2013-2014 Chair Elect, Cardiology Practice Research Network 2012-13 Chair, Programming Committee, Cardiovascular PRN for Fall session 2014 Programming Committee, Cardiovascular PRN for Fall session 2013 Programming Committee, Cardiovascular PRN for Fall session, 2012 Vice Chair , Cardiology PRN Fundraising Committee, 2012 to 2013 Cardiology PRN Mentorship Program, a Founding Mentor, 2011 to 2012 Chair, Key Articles of Dietary Intervention that Influence Cardiovascular Risk, a working

group of the Cardiovascular PRN. Spring 2010 to 2012 Programming Committee, Cardiovascular PRN for Fall session (08), 2007


35

Programming Committee, Cardiovascular PRN for Spring Session (08), 2007

Local Professional Organizations

Memphis Managed Care Corporation Heart Failure Steering Committee, Memphis Managed Care

Chair, 2005 to 2006 Member, 2005 to 2006

Memphis Managed Care Leadership Committee Member, 2005 to 2006 Diabetes Steering Committee, Memphis Managed Care Member, 2005 to 2006 Asthma Steering Committee, Memphis Managed Care Member, 2005 to 2006 Maternity Steering Committee, Memphis Managed Care Member, 2005 to 2006

Mid-South College of Clinical Pharmacy

Past President (functions on the executive committee), 2010 President, 2009 President Elect, 2008 Secretary/Treasurer, July 2000 to 2002 Chair, Mid-South College of Clinical Pharmacy Task Force on Anticoagulation,

March 2008 to December 2009 Chair, Pharmacist Impact on Medication Adherence in HF (PIMA-HF) research

group, March 2011 to 2012

Tennessee Pharmacists Association—Society of Students of Pharmacy Tennessee Society of Students of Pharmacy President, 1996-1997 Tennessee Society of Students of Pharmacy President-Elect, 1995-1996

University

University of Tennessee College of Pharmacy

Composite Examination Review Committee Chair, 2012 to 2016 Co-Chair, 2016 to present


36

Curriculum Committee Member 2017 to present Curriculum Revision Task Force Member 2012 to present Cardiology Integration Committee Subgroup 2016 to present IPECS (Inter-professional education and simulation) subcommittee Member 2012 to 2015 Academy of Students of Pharmacy, CPR Committee Faculty Co-Advisor, 2006 to present Academy of Students of Pharmacy, Operation Heart Committee Faculty Advisor, 2007 to present Dean’s Taskforce for Hypertension, Absenteeism, Presenteeism, and Adherence

Member 2009-2010

Publications/Marketing/Development Committee Member, 2009 to 2013 ACPE Self Study Committee I Member, 2007 to 2011 ACPE Self Study Curricular Effectiveness Committee Member, 2013 to 2015 DCP Strategic Planning Team 5 Member 2010 to 2011 Office of Vice Chancellor Community Outreach Think Tank (Malrie Shelton, contact)

Member, 2008 to 2010

ASHP Clinical Skills Competition Coordinating Committee, Academy of Students of Pharmacy, 2000 - present

Judge, Local Competition, 2000-2004, 2007, 2008, 2010 Faculty Mentor, First Place Team, 2000 – 2009

Faculty Enrichment Committee Member 2006 to 2007, 2009- 2012

University of Tennessee Full-time Tenure Faculty Search Committee for UTMC/UTHSC

Member, 2005 to 2006

American Pharmaceutical Association—Academy of Students of Pharmacy Chapter President, 1996-1997 Chapter President-Elect, 1995-1996 National Meeting Ambassador Committee Chair, 1995-1996


37

Hypertension Committee Chair, 1994-1995

Phi Lambda Sigma Pharmacy Leadership Society Treasurer, 1996-1997

The University of Tennessee Pharmacy Student Government Association,

Panel 1996-97 Hospital

Veterans Affairs Medical Center Memphis Pharmacy Practice Preceptor Committee Member, 2006 to present Publication Committee Member, 2018 to present Baptist Memorial Hospital Memphis

Baptist Memorial Hospital Pharmacy and Therapeutics Committee Guest in relation to cardiology pharmacotherapy issues, 1999 to 2005 Baptist Memorial Hospital Formulary Committee Guest in relation to cardiology pharmacotherapy issues, 1999 to 2005 Baptist Memorial Hospital Medication Use Evaluation Committee Guest in relation to cardiology pharmacotherapy issues, 1999 to 2005 Institute for Health Care Improvement (IHI) Heparin Committee, Baptist Hospital Member,

2004 to 2005 Acute Myocardial Infarction Committee, Baptist Memorial Hospital Memphis Member, 2001 to 2005 Cardiac Care Initiative Committee, Baptist Memorial Hospital Memphis Member, 2002 to 2005 Interventional Cardiology Committee, Baptist Memorial Hospital Memphis Member, 2001 to 2005 Heart Failure QI Committee, Baptist Memorial Hospital Memphis Member, 2002 to 2005 Chair, for ACEI Use Subgroup, 2004 to 2005 Resident Advisory Committee, Baptist Memorial Hospital Memphis Member, 2000 to 2004


38

In House Resuscitation Committee, Baptist Memorial Hospital Memphis Member, 2000 to 2004 Facilitator, Equipment Subcommittee, 2000-2001

OTHER PROFESSIONAL ACTIVITIES/ SERVICE

National Faculty, FreeCE.com Cardiovascular faculty, 2015 to present

National Faculty, ACCP Updates Plus Webinar® Updates in Cardiology. February 25, 2015.

Updates in Cardiology. February 23, 2016. National Faculty, ACCP Updates to the Updates Webinar® Cardiology I: Updates for the Pharmacotherapy Specialist. February 25th, 2014. Cardiology I: Updates for the Ambulatory Care Specialist. February 26th, 2014. National Faculty, ACCP Last Chance Webinar for Pharmacotherapy®.

Cardiology. September 5, 2012. Cardiology. September 4, 2013. Cardiology. September 3, 2014. Cardiology. September 3, 2015. Cardiology. September 6, 2016. Cardiology. September 6, 2017. Cardiology. September 5, 2018.

National Faculty, ACCP Updates in Therapeutics®: The Pharmacotherapy Preparatory Review and

Recertification Course Cardiology I, 2013, 2014, 2015, 2016, 2017, 2018

Cardiology II, 2012 National Faculty, ACCP Updates in Therapeutics®: The Cardiology Preparatory Review and

Recertification Course Acute Coronary Syndrome (Jacksonville, FL), 2018

Acute Coronary Syndrome (Pamona, CA), 2018

Content Reviewer ACCP Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2017 ACCP Ambulatory Care Preparatory Review Course (Hypertension), 2011 Pharmacotherapy Flash Cards, 2014 Critical Care Flash Cards, 2015

Item Writer, Cardiology ACCP Pharmacotherapy Mock Exam, 2015 Item Writer, American Society Hypertension-Clinical Hypertension Certification ASH-CHC Item Writer, 2015


39

Mentor, ACCP Cardiology PRN Mentorship Program This volunteer program allows those interested in cardiology to share experiences, to give back to the profession, and to guide a junior colleague in their career. Mentors are paired within the Cardiology PRN based on common goals and interests. I have served as a mentor since 2014 and have been paired with the following practitioners:

2014 Sally Arif, Pharm.D. BCPS AQ-Cardiology, Midwestern University 2015 Kathleen Faulkenberg*, Pharm.D., University of Kentucky

2016 Hua Ling, PharmD, MS, Hampton University 2017 Caitlin Gibson*, PharmD, University of North Texas 2018 Brittany Florcykowski, PharmD, The Cleveland Clinic

* Indicates mentees that I have guided through publication endeavors. Professional Reviewer, Ambulatory Care Self Assessment Program (ACSAP) 2018 ed. Chapters Reviewed:

Langford. Chronic Heart Failure, April 2017 Dixon. Primary Prevention of Cardiovascular Disease, May 2017 DiPalo. Chronic Cardiovascular Disease in the Older Patient, May 2017 Professional Reviewer, Critical Care Self Assessment Program (CCSAP), 2017 ed. Chapters Reviewed: ACLS, August 2016 Professional Reviewer, Pharmacotherapy Self Assessment Program (PSAP) VII, 2016 ed.

Chapters Reviewed: Waite. Dyslipidemia, 2015 Professional Reviewer, iForumRx Commentaries Reviewed: Bryant C, Hoffman J, McFarland MS. COMPASS trial. 2017. Professional Reviewer, Power PAK CE Dyslipidemia 2015 Professional Reviewer, Pharmacotherapy Self Assessment Program (PSAP) VIII

Chapters Reviewed:

Hurren KM. Dunham MW. Obesity and Metabolic Syndrome. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program, 2013 Book 2. Infection Primary Care. Lenexa, KS: American College of Clinical Pharmacy, 2013. Johnson SG. Clinical Pharmacogenomics. In: Murphy J, Lee M, eds. Pharmacotherapy Self Assessment Program, 2013 Book 1. Cardiology and Endocrinology. Lenexa, KS: American College of Clinical Pharmacy, 2013:83-98.

Journal Reviewer

American Journal of Medicine, 2016, 2017 Critical Care Nurse, 2009, 2010, 2011,2012 Journal of Pharmacy Practice, 2013 Pharmacotherapy, 2008, 2013 Southern Medical Journal, 2006, 2007

Reviewer, Cardiology Self Assessment Program (PSAP) VII, 2019 ed. Chapters reviewed: Kalich BA. Atrial Fibrillation


40

*This type of review is considered a publication due to the mentorship offered to the author of the chapter.

Textbook Reviewer

Hypertension chapter. In Chisholm-Burns MA, Wells BG, Schwinghammer TL, et al, editors. Pharmacotherapy: Principles and Practice. 2015. 4th ed. The McGraw-Hill Companies. Reviewed in Fall 2014.

Outpatient Diabetes Group Teaching

Baptist Memorial Hospital Memphis, August 1999-2004 Teaching basic principles, monitoring, and drug therapy

Heart Failure Clinic Group Teaching Provided individual pharmacotherapy instruction to heart failure patients at the Baptist Memorial Outpatient Cardiac Rehab clinic. August 1999-2002. (Clinic closed due to funding issues in 2002)

Psychiatric Medication Group Teaching

Provided weekly individual pharmacotherapy instruction to psychiatric patients at Methodist Healthcare—Central Hospital. August 1998 to June 1999.

CONSULTING ACTIVITIES Clinical Director of Disease Management, Consultant September 2005 to Dec 2006

Memphis Managed Care Corporation Consultant, Mid-South Health Solutions 2006 Consultant, Medical Legal Review November 2008 to present Baker Donelson Law Firm, Memphis TN. 2008, 2009, 2010, 2011,2012,2013, 2014, 2018

BLACK MCLAREN JONES RYLAND & GRIFFEE, P.C., 2011, 2012, 2013, 2015, 2016 Hall Booth Smith, P.C., 2014, 2015,2016, 2017 Hardison Law Firm, 2010, 2011, 2012,2013, 2014, 2016, 2017 Lewis Thomason, 2016, 2017, 2018 London Amburn, 2016 McDonald Kuhn, PLLC, 2012 Methodist University Hospital, Memphis TN. 2008 Sigmon Law Firm, Memphis TN 2009, 2010.

Novartis Pharmaceuticals National Speaker’s Bureau for the Cardiovascular Franchise 2006 to 2010 Sanofi-Aventis 2002- 2005 Scios 2002-2004


41

The Medicines Company 2001-2004 Wyeth Pharmaceuticals 2000-2001 POST-GRADUATE TRAINEES Residents 1999-2000 Kutay Demirkan, Pharm.D. Katie Suda, Pharm.D. Melissa Anderson (Neglia), Pharm.D. Krista Coval, Pharm.D. Shawna Nowels, Pharm.D. 2000-2001 Amy Bivens, Pharm.D. Ronald Hall, Pharm.D. Michelle Lai (Scott), Pharm.D., BCPS Krystal Edwards, Pharm.D., BCPS 2001-2002 John Kuth, Pharm.D. Eric Hadley, Pharm.D. Laine Lindley, Pharm.D. Jamie Hampton, Pharm.D. 2002-2003 Carrie Malone, Pharm.D. Lucy Lin, Pharm.D. Nikkia Bennette, Pharm.D. Jessica Lee (Chang), Pharm.D. Kamonica Craig, Pharm.D. Sepideh Alimardani , Pharm.D. Tyrone McBayne , Pharm.D. Vipul Patel , Pharm.D. 2003-2004 Heather Griffin, Pharm.D. Adele Rike, Pharm.D., BCPS Biniyam Eyasu , Pharm.D. Darego McClayton, Pharm.D. Oswald Peterson , Pharm.D. Blair Wilbert, Pharm.D. Tomi Swain, Pharm.D. Bill Trownsell, Pharm.D. 2004-2005 Dana Mingo, Pharm.D. Katie Thurman, Pharm.D. Kevin Kee, Pharm.D. 2006-2007 Lydia Hutchison, Pharm.D. Carleton Maxwell, Pharm.D.


42

Amy Hodgin, Pharm.D. Timmye Edwards, Pharm.D. 2007-2008 Josh Sullivan, Pharm.D. Stefanie Harris, Pharm.D. Jessica Sain Leech, Pharm.D. Quinn A. Czosnowski, Pharm.D. (PGY-2) 2008-2009 Lacresha Skillern, Pharm.D. May Treazvant, Pharm.D. Kathryn Connor, Pharm.D. (PGY-2) 2009-2010 Ben Erwin, Pharm.D. Maria Pham, Pharm.D. Zerine Kurian, Pharm.D. Jessica Johnson, Pharm.D. (PGY-2) 2010-2011 Julia Underwood, Pharm.D. Jennifer Neil, Pharm.D. Theresa Medling, Pharm.D. (PGY-2) Jessica Gibbs, Pharm.D. Lindsay Skomrock, Pharm.D. 2011-2012 Melissa Mahoney, Pharm.D. Nasim Roosta, Pharm.D. Kelsey Tiemann, Pharm.D. Angela Bingham, Pharm.D. (PGY-2) David Hill, Pharm.D. (PGY-2)

2012-2013 Erin Willhelm, Pharm.D. Nicole McClellen, Pharm.D. Brittany Jonap, Pharm.D. (PGY-2) Luke Knox, Pharm.D. Ada Cheng, Pharm.D. Kellye Dawson, Pharm.D.

2013-2014 Jonathan Lister, Pharm.D. John Voss, Pharm.D. (PGY-2) Julie Rust, Pharm.D. Kirsten Roberts, Pharm.D. Laura Luther, Pharm.D.

2014-2015 Brett Toney, Pharm.D. Justin Pemberton, Pharm.D. Lindsey Wells, Pharm.D. (PGY-2) 2015-2016 Katie Wassell, Pharm.D. Nick Elliott, Pharm.D.


43

Jonathan VanCleave, Pharm.D., Eric Brown, Pharm.D. (PGY-2) Penny Cronk Bland, Pharm.D. 2016-2017 Stephen Harrington, Pharm.D. Jasmine Reedus, Pharm.D. Melissa Tsui, Pharm.D. (PGY-2)

Katherine March, Pharm.D. (PGY-2) Sara Gordon, Pharm.D. Tenley Ryan, Pharm.D. Mari Vanbuskirk, Pharm.D. 2017-2018 Chris Gore, Pharm.D. Daniel Neu, Pharm.D. Devin Lavender, Pharm.D. 2018-2019 Kyle Herndon, Pharm.D. Devon Lavender, Pharm.D. RESIDENT AND STUDENT RESEARCH PROJECT MENTORING

PRescribing Alpha blockers Including praZosin in the Elderly: the PRAIZE safety study Shannon W. Finks, Chelsea C. McDonnell, Kelly C. Rogers. Approved by VAMC IRB. Primary Investigator to research project. IRB #1290683. Veterans Affairs Medical Center- Memphis. 2018-2019. Enhancing Safety of Ranolazine Use in a Veteran Population Shannon W. Finks, Allison M. Roberts, Kelly C. Rogers. Approved by VAMC IRB. Primary Investigator to research project. IRB # 1207912. Veterans Affairs Medical Center- Memphis. 2017-2018. Evaluation of proton pump inhibitors’ association with QT prolongation. Kelly C. Rogers, Chris Gore, Shannon W. Finks. Approved by VAMC IRB. IRB # 1096939. Preceptor to research project. Veterans Affairs Medical Center- Memphis. 2017-2018.

The Effects of Carvedilol in Patients with Cocaine-Induced Chest Pain. Shannon W. Finks, Sara Atyia (PharmD Candidate), Robert Parker, Pharm.D., Kelly C. Rogers, Pharm.D. Primary Investigator, Approved by VAMC IRB, #358756. Preceptor to student research project. Veterans Affairs Medical Center- Memphis. Jan 2016-Dec 2017. VAMP-IT: Veteran antiarrhythmic monitoring program-improving therapy. Kelly C. Rogers, Ezra Gabre, Katelyn Garner (Pharm.D. Candidate), Shannon W. Finks. Approved by VAMC IRB. Preceptor to research project. Veterans Affairs Medical Center- Memphis. 2016-2017. VAMP-IT: Veteran antiarrhythmic monitoring program-improving therapy.


44

Kelly C. Rogers, Ezra Gabre, Shannon W. Finks. Approved by VAMC IRB. Preceptor to research project. Veterans Affairs Medical Center- Memphis. 2016-2017.

Appropriate Monitoring to Improve Sotalol Safety and Tolerability. Kelly C. Rogers, Nick Elliott, Robert B. Parker, Shannon W. Finks. Approved by VAMC IRB. Preceptor to research project. Veterans Affairs Medical Center- Memphis. 2015-2016.

The Effects of Long Term Proton Pump Inhibitor Use in those receiving Dual Antiplatelet Therapy after Post-Percutaneous Coronary Intervention Shannon W. Finks, Pharm.D., Jennee Nickleson, Pharm.D. Candidate, Penelope Cronk Bland, Pharm.D. Candidate, Kelly C. Rogers, Pharm.D. Primary Investigator. Submitted VAMC IRB May 2013. Preceptor to student research project. July 2014-July 2015. Appropriate Monitoring to Improve Amiodarone Safety and Tolearbility. Kelly C. Rogers, Sarah Elizabeth Norrid, Robert B. Parker, Shannon W. Finks. Approved by VAMC IRB. Preceptor to research project. Veterans Affairs Medical Center- Memphis. 2014-2015. Digoxin use in Veterans with heart failure in normal sinus rhythm Wes Savage, Robert B. Parker, Kelly C. Rogers, Shannon W. Finks. Co- Investigator. Submitted VAMC IRB November 2014. Preceptor to student research project. July 2013-July 2014. Safety and Efficacy of digoxin in heart failure with atrial fibrillation Kirsten Roberts, Shannon W. Finks, Robert B. Parker, Kelly C. Rogers. Co- Investigator. Submitted VAMC IRB November 2014. Preceptor to student research project. July 2013-July 2014. The Effects of Long Term Proton Pump Inhibitor Use in those receiving Dual Antiplatelet Therapy after Post-Percutaneous Coronary Intervention Shannon W. Finks, Pharm.D., Penelope Cronk Bland, Pharm.D. Candidate, Kelly C. Rogers, Pharm.D. Primary Investigator. Submitted VAMC IRB May 2013. Preceptor to student research project. July 2013-July 2014. Effect of ethnicity on cardiovascular outcomes in patients after drug-eluting stent placement at the Memphis VAMC Leigh Anne Keough, Pharm.D., Kelly C. Rogers, Pharm.D., Shannon W. Finks, Pharm.D., Robert B. Parker, Pharm.D. Co-investigator. Approved by VAMC IRB. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2012-July 2013. Effect of ethnicity and smoking status on cardiovascular outcomes in patients after drug-eluting stent placement at the Memphis VAMC Kellye T. Dawson, Pharm.D., Shannon W. Finks, Pharm.D., Kelly C. Rogers, Pharm.D., Robert B. Parker, Pharm.D. Co-investigator. Approved by VAMC IRB. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2012-July 2013. The Effects of Carvedilol in Patients with Cocaine-Induced Chest Pain. Luke Knox, Pharm.D., Shannon W. Finks, Pharm.D., BCPS., Robert Parker, Pharm.D., Kelly C. Rogers, Pharm.D. Primary Investigator, Approved by VAMC IRB, #00764. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2012-July 2013.


45

Safety Outcomes in High Risk Patients Receiving Triple Therapy after Percutaneous Coronary Intervention Molly Kinsella, Pharm.D. Candidate, Kelly C. Rogers, Pharm.D., Shannon W. Finks, Pharm.D. Co-investigator. Approved by VAMC IRB. Preceptor to stuent research project. Veterans Affairs Medical Center- Memphis. January 2013-December 2013.

Safety Outcomes in High Risk Patients Receiving Triple Therapy after Percutaneous Coronary Intervention Jacob Marler, BS, Kelly C. Rogers, Pharm.D., Shannon W. Finks, Pharm.D. Co-investigator. Approved by VAMC IRB. Preceptor to stuent research project. Veterans Affairs Medical Center- Memphis. June 2011-July 2012.

Prospective Evaluation of Risk Factors in Veterans Leading to Heart Failure Exacerbations Sampaguita M. Wright, Pharm.D., Mark Howell, Pharm.D., Kelly C. Rogers, Pharm.D., Robert Parker, Pharm.D., Shannon W. Finks, Pharm.D. Co-investigator. Submitted to VAMC IRB. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2011-July 2012.

Effect of Ethnicity on Cardiovascular Outcomes in Patients after Drug-Eluting Stent Placement at the Memphis VAMC Kelsey Tiemann, Pharm.D., Robert Parker, Pharm.D., Shannon W. Finks, Pharm.D., Kelly C. Rogers, Pharm.D. Co-investigator. Approved by VAMC IRB. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2011-July 2012. The Effects of Carvedilol in Patients with Cocaine-Induced Chest Pain. Corry T. Johnston, Pharm.D., Shannon W. Finks, Pharm.D., BCPS., Kelly C. Rogers, Pharm.D., Robert Parker, Pharm.D. Primary Investigator, Approved by VAMC IRB, #00764. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2011-July 2012. Evaluation of Atrial Fibrillation Patients Receiving Bridging Therapy with Enoxaparin and Warfarin at the Veterans Affairs Medical Center, Memphis Julia Underwood, Pharm.D., Kelly C. Rogers, Pharm.D, Shannon W. Finks, Pharm.D., BCPS, Robbie Parker, Pharm.D.,. Approved by VAMC IRB. Co-Primary Investigator. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2010-July 2011. Changes in RIFLE Criteria after CABG Surgery in Patients with Recent Exposure to ACEIs and ARBs Jennifer Neill, Pharm.D., Shannon W. Finks, Pharm.D., BCPS., Kelly C. Rogers, Pharm.D., Ronald Braden, Pharm.D. Primary Investigator, Approved by VAMC IRB, #00663. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2010-July 2011. The Incidence of Bleeding with Enoxaparin Bridging. Johanna L. Norman, Pharm.D. Candidate, Maria Pham, Pharm.D., Kelly C. Rogers, Pharm.D, Shannon W. Finks, Pharm.D.; University of Tennessee College of Pharmacy, Memphis, TN; Approved by VAMC IRB. Co-Primary Investigator. Preceptor to student research project. Veterans Affairs Medical Center, Memphis, TN. June 2008-October 2010. Clinical Outcomes Associated with Pre-operative use of ACEIs or ARBs in CABG


46

Zerine Kurian, Pharm.D., Shannon W. Finks, Pharm.D., BCPS, Kelly C. Rogers, Pharm.D., Ronald Braden, Pharm.D. Primary Investigator, Approved by VAMC IRB. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2009-July 2010. Evaluation of Patients Receiving Bridging Therapy with Enoxaparin and Warfarin at the Veterans Affairs Medical Center, Memphis Maria N. Pham, Pharm.D., Shannon W. Finks, Pharm.D., BCPS, Kelly C. Rogers, Pharm.D. Robbie Parker, Pharm.D., Johanna Norman, Pharm.D. Candidate. Co-Primary Investigator. Approved by VAMC IRB. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2009-July 2010. Evaluation of Patients Receiving Bridging Therapy with Enoxaparin and Warfarin at the Veterans Affairs Medical Center, Memphis Lacresha Skillern, Pharm.D. Shannon W. Finks, Pharm.D., BCPS, Nick Townsend, Pharm.D., Robbie Parker, Pharm.D., Kelly C. Rogers, Pharm.D. Co-Primary Investigator. Approved by VAMC IRB. Preceptor to resident research project. Veterans Affairs Medical Center- Memphis. July 2008-July 2009. Assessment of Amiodarone Monitoring in Accordance with North American Society of Pacing and Electrophysiology (NASPE) Guidelines at the Veterans Affairs Medical Center Sarah Mizne, Kelly C. Rogers, Pharm.D., Shannon W. Finks, Pharm.D. Co-Primary Investigator. Approved by VAMC IRB. Preceptor to student research project. Veterans Affairs Medical Center- Memphis. July 2007-October 2008.

Safety and Efficacy of Triple Antithrombotic Therapy in post-PCI Veterans Lan Ngo, Pharm.D., Kelly C. Rogers, Pharm.D., Shannon W. Finks, Pharm.D., Robert Parker, Pharm.D. Co-Primary Investigator. Approved by VAMC IRB. Preceptor to PGY-1 residency project, Veterans Affairs Medical Center, Memphis. Memphis, Tennessee. October 2007 to June 2008. Racial Disparities with Statin Use in Veterans Post Myocardial Infarction. Amy B. Hulsey, Pharm.D., Shannon W. Finks, Pharm.D., Robert Parker, Pharm.D., Kelly C. Rogers, Pharm.D. Primary Investigator. Approved by VAMC IRB #00566. Preceptor to PGY-1 residency project, Veterans Affairs Medical Center, Memphis. Memphis, Tennessee. October 2007 to June 2008.

Evaluation of the Appropriate Use of Beta-Blockers in Heart Failure Carleton B. Maxwell, Pharm.D., Robert Parker, Pharm.D., Shannon Finks, Pharm.D., BCPS, Kelly Rogers, Pharm.D. Co- Investigator. Approved by VAMC IRB #00510. Preceptor to PGY-1 residency project, Veterans Affairs Medical Center, Memphis. Memphis, Tennessee. October 2006 to June 2007.

Evaluation of the Incidence of Hyperkalemia in Heart Failure Patients treated with Spironolactone Timmye Edwards, Pharm.D., Shannon W. Finks, Pharm.D., BCPS, Kelly C. Rogers, Pharm.D. Co- investigator. Approved by VAMC IRB #00502. Preceptor to PGY-1 residency project, Veterans Affairs Medical Center, Memphis. Memphis, Tennessee. October 2006 to June 2007. A Pharmacist Initiated Education Program to Improve Vaccination Rates among High Risk Medicare Patients with Heart Failure. Primary Investigator. Approved by the University of


47

Tennessee IRB. Advisor to Project Heart, University of Tennessee College of Pharmacy and Memphis Managed Care Corporation. October 2007 to June 2008. Evaluation of racial differences in the treatment of veterans with heart failure Rebecca Kirkpatrick, Emily McCoy, Kelly C. Rogers, Robert Parker, Shannon W. Finks. Primary investigator. Approved by VAMC IRB. Primary preceptor to student project, Verterans Affairs Medical Center, Memphis. Memphis, Tennessee. May –July 2005. Implementation of HomMed monitoring and impact on readmissions in a Medicaid population Anthony Whitted, M.D. candidate 2006, Shannon W. Finks, Pharm.D., BCPS, Laura Sprabery, M.D. Preceptor to medical student project, University of Tennessee College of Medicine and Memphis Managed Care Corporation. Memphis, Tennessee. October 2005 to July 2006.

Implementation of a clinical pharmacy anticoagulation monitoring program in an effort to decrease adverse drug events. Adele Rike, Pharm.D., Shannon W. Finks, Pharm.D., BCPS, Kelly C. Rogers, Pharm.D., Bryan Love, Pharm.D, BCPS, Michael Long, RPh. Preceptor to resident project, Baptist Memorial Health Care- Memphis. Memphis, Tennessee. August 2003-June 2004.

Interventions to improve anticoagulation use in percutaneous interventions. Heather Griffin, Pharm.D., Shannon W. Finks, Pharm.D., BCPS, Kelly C. Rogers, Pharm.D. Preceptor to resident project, Baptist Memorial Health Care- Memphis. Memphis, Tennessee. August 2003-June 2004.

Assessing usage of aprotinin versus epsilon-aminocaproic acid for coronary artery by-pass grafting surgery. Carrie Malone, Pharm.D. Krista Coval, Pharm.D. Shannon W. Finks, Pharm.D., BCPS Preceptor to resident project, Baptist Memorial Health Care- Memphis. Memphis, Tennessee. August 2002-June 2003. BNP levels and their influence on admission rates, discharge planning, and prescribing patterns of nesiritide in patients with heart failure. Sepideh Alimardani, Pharm.D.; Shannon Finks, Pharm.D., BCPS; Bryan Love, Pharm.D., BCPS; Katie Suda, Pharm.D. Preceptor to resident project, Baptist Memorial Health Care- Memphis. Memphis, Tennessee. August 2002-June 2003. Evaluating Risk for Adverse Drug Events from Antiplatelet and Anticoagulant Agents in Patients Undergoing Percutaneous Intervention Laine Lindley, Pharm.D., Shannon Finks, Pharm.D., BCPS, Bryan Love, Pharm.D., BCPS. Preceptor to resident project, Baptist Memorial Health Care- Memphis. Memphis, Tennessee. August 2001-June 2002.

Evaluation Of Thrombolytic Utilization In Acute Myocardial Infarction Michelle Lai, Pharm.D., Shannon Finks, Pharm.D., BCPS. Preceptor to resident project, Baptist Memorial Health Care- East. Memphis, Tennessee.

August 2000-June 2001.

Implementation of Pharmacy Driven Coumadinâ Dosing


48

Amy Bivens, Pharm.D., Shannon Finks, Pharm.D., BCPS, David Kuhl, Pharm.D. Preceptor to resident project, Baptist Memorial Health Care- East. Memphis, Tennessee.

August 2000-June 2001.

Bridging Therapy with Lovenox/ Coumadin Melissa Neglia, Pharm.D., Shannon Willhite, Pharm.D., David Kuhl, Pharm.D.

Preceptor to resident project, Baptist Memorial Health Care- East. Memphis, Tennessee. August 1999-June 2000. RESEARCH AND OTHER EXTERNAL SUPPORT

Course Directors’ Interpretation of Item Analysis and Subsequent Impact on Student Performance. Sharon K. McDonough, Shannon W. Finks. Approval pending from University of Tennessee IRB. Memphis, Tennessee. 2014 to present. Student pharmacist perceptions of a computerized integrated examination Stephanie J. Phelps, Sharon K. McDonough, Shannon W. Finks, Robert B. Parker, and Elizabeth L. Alford. Approved by University of Tennessee IRB. Memphis, Tennessee. 2012 to 2014.

Pharmacist Impact on Medication Adherence in Heart Failure (PIMA-HF). Shannon W. Finks, Pharm.D., Primary Investigator and Chair of the Mid-South College of Clinical Pharmacy PIMA-HF research group. Approval pending from University of Tennessee IRB. Memphis, Tennessee. 2011 to present. Development and Implementation of a Scorecard to Track Faculty Accomplishments Michelle Zingone, Pharm.D., Joe Presley, Pharm.D.., Shannon W. Finks, Pharm.D., Debbie Byrd, Pharm.D.. Approved by UTHSC IRB, # 11-01302-XM. 2011 to present.

Safety and Efficacy of Triple Antithrombotic Therapy in Post-PCI Veterans. Kelly C. Rogers, Pharm.D., Jacob Marler, Pharm.D. Candidate, Shannon W. Finks, Pharm.D. Co-Primary Investigator. Approved by VAMC IRB, #00567. Preceptor to student research project. Veterans Affairs Medical Center, Memphis, TN. University of Tennessee College of Pharmacy, Memphis, Tennessee. 2010 to present. Mid South College of Clinical Pharmacy Task Force on Anticoagulation. Shannon W. Finks, Pharm.D., Carrie S. Oliphant, Pharm.D., Amy H. Manguso, Pharm.D., Kelly C. Rogers, Pharm.D., Gail Bridges, Pharm.D., Cyrine-Eliana Haidar, Pharm.D., Kelley R. Lee, Pharm.D., Marilyn Lee, Pharm.D., Bob Lobo, Pharm.D., Amanda M. May, Pharm.D., Anne Reaves, Pharm.D., Joseph M. Swanson, Pharm.D., Melanie Swims, Pharm.D., Jason Vinson, Pharm.D., Mary E. D.Yates, Pharm.D. A city-wide initiative and Task Force for policy development to improve patient safety in accordance with The Joint Commission National Patient Safety Goal (NPSG) 3E. Memphis, Tennessee. 2008-2009.

Job Sharing In Pharmacy: An Innovative Opportunity in Academia.


49

Kelly C. Rogers, Pharm.D. and Shannon W. Finks, Pharm.D. An evalutation of a job-sharing experience in academia. University of Tennessee College of Pharmacy. Memphis, Tennessee. 2006- to present. Inappropriate Use of Sotalol in Renal Insufficiency: A Need for Clinical Pharmacist Intervention. Shannon W. Finks, Pharm.D., Amy H. Manguso, Pharm.D., Kelly C. Rogers, Pharm.D. Approved by Baptist Memorial Hospital IRB. A medication use evaluation and patient safety intervention for patients receiving sotalol. Baptist Memorial Hospital Memphis. Memphis, Tennessee. 2005. Pharmacist’s Impact in a Multidisciplinary Heart Failure Protocol. Shannon W. Finks, Pharm.D., Katie Suda, Pharm.D., Melissa J. Neglia, Pharm.D. An evaluation of the impact of the clinical pharmacist on a multidisciplinary heart failure team with regard to improving prescription of evidence-based pharmacotherapy. Baptist Memorial Hospital, Memphis, Tennessee. 2003. Treatment of Pelvic Inflammatory Disease in the Emergency Department: An Analysis of Appropriateness and Cost Shannon Willhite, Pharm.D., Victor Perini, M.S., Stephanie Cooke, Pharm.D., Stephanie Brenner, Pharm.D., Pamala J. Reed, Dr. PH, MPH. Resident Project, Methodist Healthcare—Central Hospital. Memphis, Tennessee. August 1998-June 1999.

BOOKS and BOOK CHAPTERS

1. Finks SW, Rogers KC. Multidisciplinary heart failure team. In: Koch KE, Lobo BL, eds. Clinical Pharmacy Services: Successful Practices in Community Hospitals. American College of Clinical Pharmacy, 2005; 69-73.

2. Rogers KC, Finks, SW, Oliphant CS,. Ischemic Heart Disease. In: Gourley DR, Eoff JC,

editors. APhA's complete review for pharmacy. 3rd ed. Castle Connolly Graduate Medical Publishing, Ltd. New York, New York. 2005;219-249.

3. Finks SW. Heart Failure Case Study. Online Case for: Helms RA, In: Helms RA, Quan DJ,

Herfindal ET, Gourley DR, eds. Textbook of Therapeutics: Drug and Disease Management. Eighth Edition. Philadelphia, PA: Lippincott, Williams & Wilkins; 2006.

4. Oliphant CS, Finks SW, Rogers KC. Ischemic Heart Disease. In: Gourley DR, Eoff JC,

editors. APhA's complete review for pharmacy. 5th ed. Castle Connolly Graduate Medical Publishing, Ltd. New York, New York. 2007;219-249.

5. Finks SW. Cardiovascular disease in women. In: Richardson M, Chessman KH, Chant C, et

al. (Eds.) Pharmacotherapy Self-Assessment Program, 7th Edition. Book 1: Cardiology III. American College of Clinical Pharmacy. Kansas City, MO. 2010: pgs. 179-199.

6. Rogers KC, Oliphant CS, Finks SW. Ischemic Heart Disease. In: Gourley DR, Eoff JC,

editors. The APhA's complete review for pharmacy. 7th ed. Washington, D.C.: American Pharmacists Association; 2010. p. 219-250.


50

7. Oliphant CS, Finks SW, Rogers KC. Ischemic Heart Disease. In: Gourley DR, Eoff JC, editors. APhA's complete review for pharmacy. 9th ed. Castle Connolly Graduate Medical Publishing, Ltd. New York, New York. 2011;259-89.

8. Finks SW, Rogers KC, Oliphant CS. Ischemic Heart Disease. In: Gourley DR, Eoff JC,

editors. American Pharmacists Association complete review for pharmacy. 10th ed. American Pharmacists Association. Washington, DC; 2013:315-47.

9. Finks SW. Cardiology I. In: Dugan J, El-Ibiary S, Foote EF, et al. Updates in Therapeutics®: The Pharmacotherapy Preparatory Review and Recertification Course, 2013 ed. Lenexa, KS: American College of Clinical Pharmacy, 2013(2):205-51.

10. Finks SW. Cardiology I. I. In: Dugan J, El-Ibiary S, Foote EF, et al. Updates in

Therapeutics®: The Pharmacotherapy Preparatory Review and Recertification Course, 2014 ed. Lenexa, KS: American College of Clinical Pharmacy. 2014(2):187-234.

11. Rogers KC, Oliphant CS, Finks SW. Ischemic Heart Disease and Acute Coronary Syndrome. In: Chyka PA, Boucher BA, Franks AS, Waddell JA, editors. The APhA Complete Review for Pharmacy. 11th ed. Washington, D.C.: American Pharmacists Association. 2015. p. 267-297.

12. Finks SW. Cardiology I. In: Burke J, Cauffield J, El-Ibiary S, et al. Updates in Therapeutics®: The Pharmacotherapy Preparatory Review and Recertification Course, 2015 ed. Lenexa, KS: American College of Clinical Pharmacy. 2015(2):103-161.

13. Rogers KC, de Denus S, Finks SW. Acute Coronary Syndromes. In Chisholm-Burns MA, Schwinghammer TL, Wells BG, et al, eds. Pharmacotherapy: Principles and Practice. 4th ed. New York: McGraw-Hill Companies; 2016:111-136.

14. Finks SW. Cardiology I. In: Burke J, Cauffield J, El-Ibiary S, et al. Updates in


15. Rogers KC, de Denus S., Finks SW, Spinler SA. Acute Coronary Syndrome. In: DiPiro J,

Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM eds. Pharmacotherapy: A Pathophysiologic Approach. Tenth Edition. New York, NY: McGraw Hill; 2017:165-192.



17. Oliphant CS, Finks SW, Rogers KC. Ischemic Heart Disease and Acute Coronary

Syndrome. In: Chyka PA, Franks AS, Waddell JA, Boucher BA, editors. The APhA Complete Review for Pharmacy. 12th ed. Washington, D.C.: American Pharmacists Association. 2017:289-319.




51

19. Finks SW. Acute Coronary Syndrome. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updates in Therapeutics®: Cardiology Pharmacy Preparatory Review Course, 2018 ed. Lenexa, KS: American College of Clinical Pharmacy, 2018:637-83.

20. Finks SW. Health Promotion, Disease Prevention, and Population Health. In: Boucher BA,

ed. The APhA Complete Review For the FPGEE. 2nd edition. Washington DC: American Pharmaceutical Association; 2018: 449-468.

21. Rogers KC, Spinler S, Finks SW. Acute Coronary Syndromes. In Chisholm-Burns MA,

Schwinghammer TL, Wells BG, et al, eds. Pharmacotherapy: Principles and Practice. 5th ed. New York: McGraw-Hill Companies; 2019

22. Dominico RD, Dobesh P, Finks SW. Acute Coronary Syndrome. In: DiPiro J, Talbert RL,

Yee GC, Matzke GR, Wells BG, Posey LM eds. Pharmacotherapy: A Pathophysiologic Approach. Eleventh Edition. New York, NY: McGraw Hill; in press.

23. Rogers KC and Finks SW. Cardiovascular disease in women. In: Richardson M, Chessman

KH, Chant C, et al. (Eds.) Cardiology Self-Assessment Program, 1st Edition. Book 1: Cardiology III. American College of Clinical Pharmacy. Kansas City, MO. 2019 in press.

PEER-REVIEWED JOURNAL ARTICLES

1. Willhite SL, Goebel SR, Scoggin JA. Raloxifene provides an alternative for osteoporosis prevention. Ann of Pharmacother. 1998;32:834-7.

2. Finks, SW. Bivalirudin Use in Carotid Endarterectomy in a patient with confirmed heparin induced thrombocytopenia. Ann Pharmacother 2006;40:340-343. DOI 10.1345/aph.1G307.

3. Finks SW, Finks AL, Self T. Hydralazine—induced lupus: maintaining vigilance with

increased use in African American patients with heart failure. Southern Medical Journal. 2006;99:18-22.

4. Finks SW, Rogers KC. Job-Sharing. Am J Health-Syst Pharm. 2008;65(1):69-72.

5. Finks SW. Re-examining the cardiovascular therapeutic benefits of aspirin. Editorial. Southern Medical Journal. 2008;101(7):679-80.

6. Airee A, Draper HM, Finks SW. Aspirin Resistance: Disparities and Clinical Implications. Review. Pharmacotherapy. 2008;28(8):999-1018.

7. Czosnowski QA, Finks SW, Rogers KC. Bivalirudin for Patients with Heparin-Induced Thrombocytopenia Undergoing Cardiac Procedures. Ann Pharmacother. 2008;42(9):1304-9.

8. Rogers KC, Finks SW, Pour OR, Thomas M, Munir A. Procainamide-induced pleural and pericardial effusions. Cardiology Review. 2009;26(3):1-6.

9. Rogers KC, Finks, SW. Job Sharing for Women Pharmacists in Academia. Am Journ Pharm

Educ Nov 2009;73(7):135.


52

10. Finks SW, Oliphant CS, Manguso AH, et al. Report of the Mid South College of Clinical

Pharmacy Task Force on Anticoagulation: National Patient Safety Goal 3E. Am J Health-Syst Pharm. 2009;66:2179-88.

11. Goddard KB, Eppert HD, Underwood LL, McLean KM, Finks SW, Rogers KC. Basic Life Support and Cardiopulmonary Resuscitation Training for Pharmacy Students and the Community by a Pharmacy Student Committee. Am Journ Pharm Educ. October 2010;74(6):100.

12. Finks SW, Rogers KC, Manguso AM. Assessment of Sotalol in a Community Hospital: Opportunities for Clinical Pharmacist Involvement. Published ahead of print. Int J Pharm Pract. 2011;19(4):281-6. DOI=10.1111_j.2042-7174.2011.00094.

13. Finks SW, Airee A, Chow S, Macaulay TE, Moranville MP, Rogers KC, Trujilio T. Key Articles of Dietary Interventions that Influence Cardiovascular Risk. Pharmacotherapy. 2012;32(4):e54-87. doi: 10.1002/j.1875-9114.2011.01087.x.

14. Rogers, KC , Faircloth JM,. Finks SW. The use of cilostazol in percutaneous coronary intervention. Review. Ann Pharmacother. 2012 Jun;46(6):839-50. Epub 2012 Jun 5. doi: 10.1345/aph.1Q765.

15. Rogers KC, Wallace JP, Foster SL, Finks SW. Annual Influenza Vaccination: Offering Protection Beyond Infection. So Med J. 2012:105:379-86. DOI: 10.1097/SMJ.0b013e31824e8db6

16. Norman JL, Holmes WL, Bell WA, Finks SW. Life-Threatening ACE Inhibitor Induced Angioedema after Eleven Years on Lisinopril. Case Report. Journal of Pharmacy Practice. 2013;26:381-7. 2012 Nov 25. [Epub ahead of print]. DOI: 10.1177/0897190012465990.

17. Dobesh P, Trujilio T, Finks SW. The role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism. Pharmacotherapy. 2013.;33(6):650-4. April 1[Epub ahead of print]. doi: 10.1002/phar.1244.

18. Phelps SJ, McDonough SK, Parker RB, Finks SW. Throwing a Curveball: The Impact of Instructor Decisions Regarding Poorly Performing Test Questions. Corresponding Author. Am Journ Pharm Educ. 2013 Nov 12;77(9):204. doi: 10.5688/ajpe779204.

19. Finks SW, Campbell JD. Avoiding Patient Morbidity: Updated Statin Drug Interactions and Risks for Patient Harm. Nurse Practitioner. 2014:39(11):45-51. doi: 10.1097/01.NPR.0000443232.02852.f8.

20. Finks SW, Ripley TL. Sorting it out: What JNC8 is and what JNC8 is not. Primary and Corresponding author. Journal of Managed Care and Specialty Pharmacy. 2015;21(2):110-12.

21. Rogers KC, Oliphant CO, Finks SW. "Clinical Efficacy and Safety of Cilostazol: A Critical Review of the Literature". Drugs. 2015;75(4):377-95. DOI: 10.1007/s40265-015-0364-3.


53

22. Ripley TL, Brenner M, Finks SW, Hough A, McConnell KJ, Parker M, Dobesh P. Key Articles and Guidelines in the Management of Hypertension: 2014 Update. Journal of Pharmacy Practice. 2015;28(2):146-161. DOI: 10.1177/0897190014568382

23. Faulkenberg KD, Beavers JC, Finks SW. A review of heparin versus bivalirudin monotherapy in the setting of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction. Ann Pharmacother. 2016 Feb;50(2):141-51. doi: 10.1177/1060028015618206. Epub 2015 Dec 17.

24. Finks SW, Trujillo TC, Dobesh PP. Management of venous thromboembolism: Recent

advances in oral anticoagulation therapy. Ann Pharmacother. 2016;50(6) 486–501. DOI: 10.1177/1060028016632785

25. McDonough SLK, Alford EL, Finks SW, Parker RB, Chisholm-Burns MA, Phelps SJ. First

professional year student pharmacists perceptions of a composite examination. AJPE. 2016 Feb 25;80(1):4. doi: 10.5688/ajpe8014.

26. Rogers KC, Shelton MP, Finks SW. ReversalAgentsforDirectOralAnticoagulants:UnderstandingNewandUpcomingOptions.CardiolinRev.2016:24(6):310-15.

27. Finks SW, Rogers KC. Praxbind: The first reversal agent for a direct oral anticoagulant. Am Journ

Med 2017;130(5):e195-97. doi: 10.1016/j.amjmed.2016.11.029.

28. Shah R, Finks SW. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention. Cardiovas Diagn Ther. 2017;7(Suppl 2):S66-68.

29. Hellenbart E, Faulkenberg KD, Finks SW. Evaluation of bleeding incidence in patients

receiving direct oral anticoagulants. Vasc Health Risk Manag. 2017;13:325-42.

30. Gibson CM, Finks SW. Edoxaban: How does the newest agent fit into the DOAC landscape? Am Journ Med. 2017;130(8):900-906.

31. Finks SW, Dobesh PP, Trujillo TC, Crossley G. Periprocedural management of direct oral

anticoagulants surrounding cardioversion and invasive electrophysiological procedures. Cardiol Rev. 2018;26:245-54.

32. 33.

ARTICLES IN PRESS

1. Trujillo TC, Dobesh PP, Crossley G, Finks SW. Contemporary Management of Direct Oral

Anticoagulants During Cardioversion and Ablation for Non-Valvular Atrial Fibrillation. Pharmacotherapy. Accepted October 2018.


54

2. Dobesh PP, Finks SW, Trujillo TC. Similarities and Differences of Oral Antiplatelet Agents

for ACS Management: An Antiplatelet review. In press.

3. Finks SW, Self TH, Rumbak. Hypertension in Asthma and COPD Patients. Commissioned review. NEJM. Submitted April 2018.

4. Finks SW, Page RL 2nd. Tips, Tactics, and Technology for Improving Medication Adherence.

Commissioned article. Heart. In press. 5. Rogers KC, Neu D, Jaeger M, Shah, R, Finks SW. An underappreciated and prolonged drug

interaction leads to ineffective anticoagulation. Southern Medical Journal. Accepted June 2018.

6. Rogers KC, Finks SW. A New Option for Reversing the Anticoagulant Effect of Factor Xa

Inhibitors: Andexanet alfa (Andexxa®). American Journal of Medicine. Accpeted July 2018.

ABSTRACTS PRESENTED AND PUBLISHED

1. Willhite S, Perini V, Cooke S, Brenner S, Reed PJ. Treatment of Pelvic Inflammatory Disease in the Emergency Department: An Analysis of Appropriateness and Cost. 1999 Annual Meeting Abstracts. American Society of Health Systems Pharmacists. Reno, NV. June 8,1999.

2. Anderson MA, Finks SW, Coval K, Shellabarger C, Kuhl D. The Clinical Pharmacist’s Role in Implementing Expanded Indications for Low Molecular Weight Heparin Bridging Program. Abbott Laboratories National Hospital Pharmacy Quality Award Program Finalist. Presented at ASHP Midyear meeting. New Orleans Louisiana, December 2, 2001.

3. Coval K, Finks SW, Kuhl, D. The Clinical Pharmacist’s Role in Providing Safe Dofetilide Medication Use: Initiation of a Critical Pathway to Avoid Adverse Drug Events and Complications from Antiarrhythmic Therapy. Abbott Laboratories National Hospital Pharmacy Quality Award Program Finalist. Poster presentation at ASHP Midyear meeting. New Orleans Louisiana, December 2, 2001.

4. Anderson MA, Finks SW, Kuhl D, McGrew FA, Gubin S. Expanded Use of Low Molecular Weight Heparin for Warfarin Bridging. 2001 Spring Practice and Research Forum Abstracts. American College of Clinical Pharmacy, Salt Lake City, UT. April 2001.

5. Finks SW, Suda, KJ, Neglia MJ, Northern, MA. Pharmacist’s impact in a Multidisciplinary Heart Failure Protocol. 2003 Spring Practice and Research Forum Abstracts. American College of Clinical Pharmacy Palm Springs, California. April 2003.

6. Griffin HL, Finks SW, Rogers KC, Love BL. Anticoagulation Use and Bleeding Complications in Percutaneous Coronary Interventions. 2004 Midyear Meeting Abstracts. American Society of Health Systems Pharmacy, New Orleans, LA. December 2004.

7. Rogers KC, Finks SW, Solomon DK, Helms RA. Job Sharing In Pharmacy: An Innovative Opportunity in Academia. 2007 ACCP Spring Practice and Research Forum Abstracts, Abstract


55

119. Poster presentation at the American College of Clinical Pharmacy Spring Practice and Research Forum. Memphis, TN. April 24th, 2007.

8. Finks SW, Manguso AH, Rogers KC. Inappropriate Use of Sotalol in Renal Insufficiency: A Need for Clinical Pharmacist Intervention. 2007 ACCP Spring Practice and Research Forum Abstracts, Abstract 116. Poster presentation at the American College of Clinical Pharmacy Spring Practice and Research Forum. Memphis, TN. April 24th, 2007.

9. Kirkpatrick R, McCoy EK, Rogers KC, Parker RB, and Finks SW. Evaluation of racial differences in the treatment of veterans with heart failure (HF). 2007 Annual Meeting of the American College of Clinical Pharmacy, Abstract 337. Poster presentation at the American College of Clinical Pharmacy Annual Meeting. Denver, CO. October 15th, 2007.

10. Edwards TL, Rogers KC, Parker RB, Finks SW. Evaluation of the Incidence of Hyperkalemia in Heart Failure Patients treated with Spironolactone. 2007 Annual Meeting of the American College of Clinical Pharmacy, Abstract 313. Poster presentation at the American College of Clinical Pharmacy Annual Meeting. Denver, CO. October 16th, 2007.

11. Maxwell CB, Finks SW, Rogers KC, Parker RB. Evaluation of appropriate beta-blocker use in patients with heart failure. 2007 Annual Meeting of the American College of Clinical Pharmacy, Abstract 311. Poster presentation at the American College of Clinical Pharmacy Annual Meeting. Denver, CO. October 16th, 2007.

12. Mizne S, Finks SW, Rogers KC. Assessment of amiodarone monitoring in accordance with North American Society of Pacing and Electrophysiology (NASPE) guidelines at the Veterans Affairs Medical Center Memphis. 2008 Annual Meeting of the American College of Clinical Pharmacy, Abstract 293. Poster presentation at the American College of Clinical Pharmacy Annual Meeting. Louisville, KY. October 20th, 2008.

13. Swanson JM, Finks SW, Manguso AH, Oliphant C. Mid-South college of clinical pharmacy: enhancing clinical pharmacy practice for our members. 2008 Annual Meeting of the American College of Clinical Pharmacy, Abstract 270. Poster presentation at the American College of Clinical Pharmacy Annual Meeting. Louisville, KY. October 20th, 2008.

14. Ngo L, Finks SW, Parker RB, Rogers KC. Safety and Efficacy of Triple Antithrombotic Therapy in post-PCI Veterans. 2008 Annual Meeting of the American College of Clinical Pharmacy, Abstract 38. Poster presentation at the American College of Clinical Pharmacy Annual Meeting. Louisville, KY. October 22nd, 2008.

15. Hulsey AB, Finks SW, Rogers KC, Parker RB. Evaluation of Racial Disparities with Statin Use in Veterans Post Myocardial Infarction. 2008 Annual Meeting of the American College of Clinical Pharmacy, Abstract 32. Poster presentation at the American College of Clinical Pharmacy Annual Meeting. Louisville, KY. October 22nd, 2008.

16. Skillern L, Finks SW, Parker RB, Townsend N, Rogers KC. Evaluation of Patients Receiving Bridging Therapy with Enoxaparin and Warfarin at the Veterans Affairs Medical Center, Memphis. Mid-South Residency Conference. Memphis, TN. April 23, 2009.

17. Mizne S, Rogers KC, Finks SW. Assessment of amiodarone monitoring in accordance with North American Society of Pacing and Electrophysiology (NASPE) guidelines at the Veterans


56

Affairs Medical Center Memphis. Poster presentation at the 2009 Mid-South College of Clinical Pharmacy Research Symposium. Memphis, TN. June 11th, 2009.

18. Afolabi T, Enekwa CE, Madere T, Moore L, Nelson T, Stupar J, Finks SW, Rogers KC. Mass CPR Training and Health Fair: UT Students Enhance Community Knowledge of Life Saving Skills and Health Risks. Poster presentation at Tennessee Society of Hospital Pharmacist’s 2010 Midyear Seminar/ Tennessee Pharmacists Association 2010 Midyear Meeting. Nashville, TN. February 21, 2010.

19. Norman, JL, Pham M, Rogers KC, Finks SW. The Incidence of Bleeding with Enoxaparin Bridging. Finalist, American College of Clinical Pharmacy’s Best Resident and Student Poster competition. 2010 Annual Meeting of the American College of Clinical Pharmacy, Abstract #302F. Austin, TX. October 18th, 2010.

**Awarded Best Student Poster

20. Pham M, Norman JL, Rogers KC, Finks SW, Parker RB. Risk of Bleeding with Enoxaparin Bridging Therapy in Veterans with Atrial Fibrillation. Finalist, American College of Clinical Pharmacy’s Best Resident and Student Poster competition. 2010 Annual Meeting of the American College of Clinical Pharmacy, Abstract #114F. Austin, TX. October 19th, 2010.

21. Marler J, Armstrong H, Chinn B, Madere T, Maynard M, Nason TP, Smetana K, Rogers KC, Finks SW. Impact of Pharmacy Student Health Fair on Residents of the Local UT Campus Community. Poster Presentation at 2011 Tennessee Society of Health-System Pharmacists (TSHP) Midyear Seminar. Nashville, TN. February 27th, 2011.

22. Underwood JM, Rogers KC, Pham M, Parker RB, Finks SW. Evaluation of bleeding risk using HAS-BLED scoring in patients with atrial fibrillation receiving enoxaparin bridging therapy. 2011 Annual Meeting of the American College of Clinical Pharmacy, Abstract # 356. Pittsburgh, PA. October 18, 2011.

23. Neill J, Finks SW, Braden R, Rogers KC. Changes in RIFLE Criteria after Coronary Artery Bypass Graft Surgery in Patients with Recent Exposure to Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers. 2011 Annual Meeting of the American College of Clinical Pharmacy, Abstract # 35. Pittsburgh, PA. October 18th, 2011.

24. Marler JL, Rogers KC, Finks SW. Bleeding risks in Atrial Fibrillation Patients Requiring Triple Therapy Post Percutaneous Coronary Intervention. Poster Presentation at Third Annual Meeting of the Tennessee Society of Student Pharmacists (TSSP). Belmont University, Nashville, TN. February 25th, 2012.

25. Taylor C, Finks SW, Parker RB, Rogers KC. The Effects of Carvedilol in Patients with Cocaine-Induced Chest Pain. Mid-South Residency Conference. Memphis, TN, May 4, 2012.

26. Wright SA, Rogers KC, Finks SW, Parker RB, Howell M. Prospective Evaluation of Medications Affecting Heart Failure Exacerbations in Veterans in a Multidisciplinary Heart Failure Clinic. Mid-South Residency Conference. Memphis, TN, May 4, 2012.

27. Tiemann KA, Parker RB, Rogers KC, Finks SW. Effect of Ethnicity on Cardiovascular Outcomes in Patients after Drug-Eluting Stent Placement at the Memphis VAMC. Mid-South Residency Conference. Memphis, TN, May 4, 2012.


57

28. Marler JL, Finks SW, Rogers KC. Safety outcomes in high risk patients receiving triple therapy

after percutaneous coronary intervention. Finalist, American College of Clinical Pharmacy’s Best Resident and Student Poster competition. ACCP 2012 Virtual Poster Symposium, May 22-24, 2012. Pharmacother 2012;32(5)e108-e133.

29. Finks SW, Johnston CT, Parker RB, Rogers KC. The effects of carvedilol in patients with

cocaine-induced chest pain. 2012 Annual Meeting of the American College of Clinical Pharmacy, Abstract # 38. Hollywood, FL. October 24th, 2012.

30. Knox L, Finks SW, Parker RB, Rogers KC. The Effects of Carvedilol in Patients with Cocaine-Induced Chest Pain. Mid-South Residency Conference. Memphis, TN, April 25th, 2013

31. Dawson KT, Finks SW, Rogers KC, Parker RB. Effect of ethnicity and smoking status on cardiovascular outcomes in patients after drug-eluting stent placement at the Memphis VAMC. Mid-South Residency Conference. Memphis, TN, April 25, 2013.

32. Keough LA, Rogers KC, Finks SW, Parker RB. Effect of Ethnicity on Cardiovascular Outcomes in Patients after Drug-Eluting Stent Placement at the Memphis VAMC. Mid-South Residency Conference. Memphis, TN, April 25, 2013.

33. Finks SW, McDonough SK, Parker RB, Stewart-Outten J, Phelps SJ. An Integrated Examination for a Non-Integrated Curriculum. AACP Annual Meeting, Pharmacy Education 2013. Chicago, IL. July 13, 2013.

34. Kinsella M, Finks SW, Rogers KC. Safety Outcomes in High Risk Patients Receiving Triple Therapy after Percutaneous Coronary Intervention. 2013 Annual Meeting of the American College of Clinical Pharmacy, Abstract # 301. Albuquerque, New Mexico. October 14th, 2013.

35. Roberts K, Finks SW, Parker RB, Rogers KC. Safety and Efficacy of digoxin in heart failure with atrial fibrillation. Presented at Mid-South Residency Conference. Memphis, TN, April 24, 2014.

36. Savage W, Parker RB, Rogers KC, Finks SW. Digoxin use in Veterans with heart failure in normal sinus rhythm. Presented at Mid-South Residency Conference. Memphis, TN, April 24, 2014.

37. Phelps SJ, McDonough SK, Finks SW, Parker RB, and Alford EL. Student pharmacist perceptions of a computerized integrated examination. AACP Annual Meeting, Pharmacy Education 2014 Grapevine, TX. July 26th, 2014.

38. Rogers KC, Finks SW, Chisolm-Burns M, Phelps SJ. Stayin’ Alive: Student Pharmacists Bringing The Life Saving Skills of CPR to the Community. AACP Annual Meeting, Pharmacy Education 2014 Grapevine, TX. July 26th, 2014.

39. Roberts KM, Savage RW, Parker RB, Finks SW, Rogers KC. Impact of Digoxin use in veterans with heart failure with reduced ejection fraction. Presented at 2014 Annual Meeting of the American College of Clinical Pharmacy, Abstract #301. Austin, Texas. October 13th, 2014.


58

40. Cronk PB, Rogers KC, Finks SW. Effects of Long Term Proton Pump Inhibitor Use in Those Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention. Presented at 2014 Annual Meeting of the American College of Clinical Pharmacy, Abstract #427. Austin, Texas. October 14th, 2014.

41. McDonough SLK, Alford EA. Finks SW, Parker RB, Chisholm-Burns MA, Phelps SJ. Student pharmacist perceptions of a computerized integrated examination. Paper presented in the session: Assessment of Learners in Educational Programs for the Professions at the Annual Meeting of the American Educational Research Association, Chicago, Illinois. April 20, 2015.

42. Norrid SE, Parker RB, Finks SW, Rogers KC. Appropriate Monitoring to Improve Amiodarone Safety and Tolearbility. Presented at Mid-South Regional Pharmacy Residency Conference. Fogelman Business Center. Memphis, TN, April 23-24, 2014.

43. Nickleson, JA, Cronk PB, Rogers KC, Finks SW. Effects of Long Term Proton Pump Inhibitor Use in Those Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention. Presented at ACCP 2015 Virtual Poster Symposium, May 19, 2015. Poster #70.

44. Norrid SE, Finks SW, Parker RB, Rogers KC. Appropriate monitoring to improve amiodarone safety and tolerability. Presented at American College of Clinical Pharmacy Global Conference Meeting. Abstract #347. San Francisco, California. October 19, 2015.

45. Finks SW, Brenner M, Kemp DW, Odum LE, Parker M, Parker RB, Rogers KC. Effects of Carvedilol after Cocaine Induced Chest Pain. Presented at American College of Clinical Pharmacy Global Conference Meeting. Abstract #18. San Francisco, California. October 21, 2015.

46. Elliott N, Finks SW, Rogers KC. Appropriate monitoring to improve sotalol safety. Mid-

South Residency Conference. Memphis, TN, April 22, 2016.

47. Rogers KC, Elliott NT, Greiner LE, Majaj N, Brenner M, Finks SW. Appropriate monitoring to improve sotalol safety. Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy. 2016 –Hollywood, FL. Abstract #200.

48. Gabre E, Finks SW, Rogers KC. VAMP-IT: Veteran antiarrhythmic monitoring program-

improving therapy. Mid-South Residency Conference. April 20, 2017. Memphis, TN.

49. Atyia S, Rogers KC, Finks SW. Effects of carvedilol prescribed at discharge in patients with cocaine-induced chest pain. Program and Abstracts of the 52nd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 4, 2017 – Orlando, Fl Abstract # 2-336.

50. Jaeger M, Finks SW, Neu D, Rogers KC. Transitions of care nightmare: Induction of an enzyme leads to a reduction in anticoagulant efficacy. Program and Abstracts of the 52nd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 4, 2017 – Orlando, Fl Abstract # 2-340.

51. Rogers KC, Gabre E, Elliott N, Garner K, Finks SW. VAMP-IT: Veteran antiarrhythmic

monitoring program-improving therapy. ACCP Updates in Therapeutics® 2018 – Jacksonville, Florida. Abstract # F-19.


59

52. Gore C, Rogers KC, Finks SW. Evaluation of proton pump inhibitors’ association with QT

prolongation. Mid-South Residency Conference. April 2018- Memphis, TN. 53. Childress MB, Rogers KC, Finks SW. Ranolazine in refractory angina in a patient with end

stage renal disease. Program and Abstracts of the 53rd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 2, 2018 – Anaheim, CA. Abstract # 3-387.

54. McDonnell CC, Regen SM, Rogers KC, Finks SW. PRescribing Alpha blockers Including

praZosin in the Elderly: the PRAIZE safety study. Program and Abstracts of the 53rd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 2, 2018 – Anaheim, CA. Abstract # 1-349.

NON-PEER-REVIEWED PUBLICATIONS

1. Willhite SL. Making a difference. Tenn Pharm. 1996:32:7:11.

2. Phipps J, Willhite SL. Focus on service—nothing short of rewarding. Tenn Pharm .

1997;33:1:15.

3. Goebel SR, Willhite SL. Calcium: Adequate intake is crucial during adolescence. US Pharm. October 1998:50-6.

4. Willhite SL. Clinical Considerations of Anticoagulation Therapy. Drug Therapy Applications, an official publication of the Pharmacy and Therapeutics Committee and the Department of Pharmacy Services at Baptist Memorial Hospital, Memphis, TN. March 2000.

5. Willhite SL. Introducing…Amiodarone. Focus on Nursing, The Spirit of Caring at BMHCC. Vol 5. No. 5. May 2000.

6. Willhite SL. Plugged into Pharmacy: introducing amiodarone. Baptist Trinity Home Care and Hospice. HealthCare Services News for Supplemental Staffing. Vol 3. July/ August 2000.

7. Finks SW. Charge to the Class of 2010: Count, Dispense, and Care. Tenn Pharm. 2010;47(3): 16-7.

8. Finks SW, Nissen SE. First do no harm: proven and possible adverse effects of complementary and alternative medicine. ACCEL. 2013;46(6):Disc 3. Number 4.

shannon willhite finks - uthsc · shannon w. finks, pharm.d., fccp, bcps, bccp, ahscp-chc 1...

Documents